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osteocytes during juvenile skeletal development and adult bone adaptation 
Emily R. Moore 
 Primary cilia are sensory organelles that facilitate early skeletal development, as well as 
maintenance and adaptation of bone later in life. These solitary, immotile organelles are known 
to be involved in cell differentiation, proliferation, and mechanotransduction, a process by which 
cells sense and covert external physical stimuli into intracellular biochemical signals. Bone is a 
metabolically active tissue that continuously recruits osteogenic precursors and relies on 
osteocytes, the sensory cells of bone, to coordinate skeletal maintenance. Overall bone quality is 
dependent on the integrity of the initial structure formed, as well as this organ’s ability to adapt 
to physical loads. Proper differentiation and controlled proliferation of osteogenic progenitors are 
critical to the initial formation of the skeleton, while osteocyte mechanotransduction is essential 
for adaptation of developed bone. These phenomena rely on primary cilia, but little is known 
about the origin of osteogenic precursors and the ciliary mechanisms that promote osteogenesis.        
In this thesis, we first characterize an osteochondroprogenitor (OCP) population that 
rapidly and extensively populates skeletal tissues during juvenile skeletal development (Chapter 
2). We also demonstrate that the primary cilium is critical for these cells to differentiate and 
contribute to skeletogenesis. We then show this OCP population is required for adult bone 
adaptation and is mechanoresponsive (Chapter 3). Again, we demonstrate that primary cilia are 
necessary for these OCPs to sense physical stimuli and differentiate into active bone-forming 
cells. Finally, we identify a novel link between ciliary calcium and cAMP dynamics in the 
 
 
osteocyte primary cilium (Chapter 4). Specifically, we show that a calcium channel (TRPV4) 
and adenylyl cyclases, which produce cAMP, bind calcium to mediate calcium entry and cAMP 
production, respectively, and these phenomena are critical to fluid flow-induced osteogenesis. 
Collectively, our results demonstrate that an easily extracted progenitor population is pre-
programmed towards an osteogenic fate and extensively contributes to bone generation through 
primary cilium-mediated mechanisms at multiple stages of life. Furthermore, we identified 
ciliary proteins that are potentially unique to the osteocyte and can be manipulated to encourage 
osteogenesis by tuning calcium/ cAMP dynamics. For these reasons, we propose that this OCP 
population and their primary cilia, as well as osteocyte ciliary proteins that coordinate calcium/ 
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Chapter 1: Introduction 
Due to advances in other areas of human disease and health, older generations are 
increasingly suffering from skeletal deficiencies and abnormalities. One of the most prevalent 
bone diseases in older populations is osteoporosis, whereby bones become brittle and weak due 
to loss of tissue. Osteoporosis is characterized by low bone mineral density (BMD) and affects a 
significant portion of adults in the United States. In fact, the Centers for Disease Control and 
Prevention (CDC) National Center for Health Statistics (NCHS) report that between 2005 and 
2010, 5.1% of men and a staggering 24.5% of women in the U.S. the age of 65 and older 
suffered from osteoporosis of the hip and/ or spine1. Additionally, the NCHS found that 44.0% of 
men and 52.3% of women had low bone mass as defined by the World Health Organization’s 
(WHO) diagnostic criteria1. Collectively, it is estimated that 44 million people over the age of 50 
have low bone mass or osteoporosis and represent 55% of the U.S. population2.  
Osteoporosis is the most common cause of bone fractures, which pose a major public 
health concern and place significant financial strain on the U.S. economy2. 300,000 people in the 
U.S. over the age of 65 are hospitalized each year for hip fractures alone3 and 30% of these cases 
are expected to result in death4. In general, fractures are associated with high rates of mortality 
and decreased quality of life5,6. Over 1 million surgeries performed each year in the US involve 
fracture repair, partial excision of bone, and grafting7,8. The average hospital cost associated with 
fractures is $13,000 per patient9 and $2.5 billion are currently spent on bone grafts10. The number 




Although notable strides have been made in understanding bone diseases, current 
therapeutics are far from effectively treating osteoporosis and fractures. Bisphosphonates are 
known to inhibit resorption of bone tissue and are frequently administered orally or 
intravenously to increase BMD and prevent fractures. They have displayed some clinical 
success12 but their effectiveness is limited due to poor patient compliance and failures in 
persistence of therapy13. Additionally, a variety of health complications associated with 
bisphosphonate treatment have emerged12, such as hypocalcemia14, atypical fractures15–21, and 
impaired fracture healing22. In 2001, sclerostin protein was found to increase bone resorption in 
order to suppress bone formation23 and recent studies suggest sclerostin antibody treatment has 
extreme promise in enhancing bone mass, strength, and formation24–26 without sacrificing bone 
quality27. However, clinical studies are very preliminary and adverse effects, such as 
osteonecrosis of the jaw and atypical fracture28, have already been identified. This is perhaps not 
surprising since atypical fracture is associated with antiresorptive treatments29. In fracture repair, 
50% of bone grafts used in surgical procedures fail due to limited availability, donor site 
morbidity, and insufficient mechanical properties30–32. The most successful advances in bone 
regeneration involve a substrate that harbors cells capable of differentiating into bone-forming 
cells33,34; however, extracting cells from patients can be very painful and the acquired cells 
require complex in vitro guidance to an osteogenic lineage33. Thus, generating bone and 
enhancing bone quality in patients is a significant unmet need.  
An attractive target for enhancing bone formation is the primary cilium, a solitary 
antenna-like sensory organelle that projects from the cell surface. The primary cilium is present 
on signaling cells embedded in bone (osteocytes), bone-forming cells (osteoblasts), and stem and 
progenitor cells that are known to differentiate into osteoblasts. Our lab’s previous work 
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indicates the cilium is critical for osteocytes35,36 and osteoblasts37,38 to respond to mechanical 
stimulation in an osteogenic manner. Additionally, stem cells with osteogenic potential require 
primary cilia to guide their differentiation into osteoblasts39,40 and subsequently form bone41. 
Recently, we discovered that an FDA-approved treatment for hypertension is capable of 
enhancing osteocyte-mediated osteogenesis by lengthening, and therefore sensitizing, the 
primary cilium42. These studies suggest that the primary cilium may be an effective tool for 
treating osteoporosis in a pro-osteogenic manner, as opposed to an antiresorptive strategy, and 
therefore minimize adverse therapeutic effects, such as atypical fracture. 
 Bone tissue is a dynamic, self-repairing organ and its growth and adaptation can be 
studied in order to recapitulate natural skeletal phenomena in regenerative therapeutics. The 
skeleton was once believed to be an inert structure solely responsible for support, but has since 
been found to continuously regenerate itself through the process of bone remodeling and further 
plays a role in locomotion, calcium balance, and endocrine signaling43. In fact, cortical bone 
turns over at a rate of 2-3% each year and the rate is even higher in trabecular bone44. One 
commonly studied natural occurrence in bone physiology is development, which involves the 
initial formation and growth of the skeleton via intramembranous and endochondral ossification. 
Osteoblasts are directly recruited to lay down appositional layers of bone in intramembranous 
ossification, whereas cartilage cells (chondrocytes) undergo a program of differentiation before 
undergoing apoptosis or differentiating into osteoblasts45,46 to produce bone via endochondral 
ossification. Both forms are prevalent in embryonic and juvenile development and the primary 
cilium is known to be critical for embryonic skeletogenesis47. A second natural skeletal 
phenomenon is adult bone adaptation, whereby the mature skeleton generates more bone in 
response to heightened exposure to physical forces. Our lab has demonstrated that the primary 
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cilium and its associated proteins are necessary for normal adult bone formation37,41,48. A third 
mechanism of naturally occurring bone generation is fracture healing. In response to trauma, 
inflammatory cells, bone cells, stem cells, and osteogenic precursors (osteochondroprogenitors) 
from periosteal tissue surrounding bone coordinate the repair of broken bone into a fully 
integrated, ossified segment of new tissue with comparable mechanical properties. It has been 
suggested that the primary cilium is important in bone healing49, but this sensory organelle’s role 
is yet to be concretely established in the context of fracture repair. Overall, it is known that bone 
is inherently capable of generating more tissue but further research must be done to reveal the 
underlying mechanisms that trigger osteogenesis. It is believed that these insights are critical to 
developing truly regenerative techniques that produce fully integrated, mechanically suitable 
bone in patients with insufficient BMD and poor bone quality. Furthermore, the primary cilium 
appears to play an important role at all stages of skeletal growth and adaptation, making it a 
potential therapeutic target for in vivo bone regeneration. 
Due to the potential importance of osteogenic precursors and cilia in the normal program 
of bone development, adaptation, and repair, we chose to examine the role of an understudied 
progenitor source and its cilia, as well as a potentially unique signaling mechanism in the 
osteocyte primary cilium. In Chapter 1 of this thesis, we track the fate of progenitor cells initially 
residing in the periosteum and perichondrium, a thin coating surrounding bone and cartilage, 
respectively, during juvenile skeletal development. Furthermore, we assess the effects of cilium 
disruption on this progenitor source’s contribution to postnatal skeletogenesis. In Chapter 2, we 
determine the role of the aforementioned periosteal progenitors in adult bone formation and 
characterize their response to mechanical stimulation. In Chapter 3, we establish a relationship 
between two signaling cascades in the cilium and identify strategies to enhance osteocyte 
5 
 
osteogenesis by adjusting cilium-associated protein levels. The goal of this research is to 
motivate pro-osteogenic approaches to combat the debilitating effects of osteoporosis. 
Specifically, we seek to encourage the use of an underappreciated pool of progenitor cells for 
surgical grafting in the immediate future and in vivo regenerative therapeutics on a long-term 
scale. Additionally, we propose a molecular mechanism that may eventually be 
pharmacologically manipulated to sensitive osteocyte cilia and encourage bone formation.  
 
Background and Terms 
1.1 Bone Cells 
The following cells play an important role in the development and maintenance of bone. It is 
also important to note that these cell types often communicate with each other to holistically 
maintain the structure and function of bone. Furthermore, they all possess primary cilia (Section 
1.4) and are thought to be mechanosensitive (Section 1.2). 
Osteoblasts: bone-forming cells. These cells produce and secrete matrix proteins that ultimately 
become mineralized bone. A population of quiescent osteoblast-like cells line the cortical bone 
surface and are believed to facilitate signaling between other bone cells to ensure proper bone 
maintenance50. These “old osteoblasts” are referred to as bone lining cells and they are 
hypothesized to be first responders when the adult skeleton requires new cortical bone51. 
Specifically, it is believed that bone lining cells are triggered to deposit new bone matrix or 
differentiate into active osteoblasts in immediate response to mechanical stimulation.   
Osteoclasts: bone-resorbing cells. These multinucleated cells secrete digestive enzymes that 
break down mineralized bone tissue, usually making way for osteoblasts to form new bone. 
Osteoporosis is perhaps a result of overactive osteoclasts, which resorb more bone than the 
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body’s osteoblasts can replace. Current osteoporosis therapies, such as bisphosphonates and 
sclerostin antibody, attempt to restrict osteoclast activity in order to increase bone mineral 
density and are therefore called antiresorptives. 
Osteocytes: bone-signaling cells. Osteocytes are embedded in cortical bone and reside in fluid-
filled pockets called lacunae. Lacunae are connected via canaliculi. This lacunar-canalicular 
system allows for osteocytes to efficiently communicate with each other and other bone cells to 
coordinate formation, resorption, and overall skeletal maintenance. For example, osteocytes are 
known to directly activate osteoblast-mediated bone formation and osteoclast-mediated 
resorption. 
Chondrocytes: cells that secrete cartilage matrix and embed themselves in cartilaginous tissue. 
These cells create structural templates during skeletal development and fracture repair, and make 
up the growth plate (Section 1.5), which is responsible for limb elongation during development. 
Furthermore, hypertrophic chondrocytes in the growth plate are known to become osteoblasts46.  
Mesenchymal stem cells: multipotent cells that can differentiate into a wide variety of cell 
types. Mesenchymal stem cells (MSCs) are generally associated with bone marrow but can also 
be found in adipose tissue, bone, lung, and peripheral blood in adults, as well as umbilical cord 
blood, placenta, and fetal tissues52. Due to their differentiation potential, many current strategies 
employ MSCs to regenerate a wide array of tissues, including bone. 
Periosteal osteochondroprogenitors: cells residing in the periosteum that are capable of 
differentiating into osteoblasts and chondrocytes. Similar to MSCs, progenitors are able to 
differentiate into another cell type; however, progenitors are already committed to a more 
specific lineage. The periosteum is a thin covering surrounding cortical bone and has two distinct 
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layers. The outer fibrous layer primarily contains fibroblast-like cells that secrete matrix to give 
the periosteum its structure. The inner cambium layer, or “osteogenic layer”, contains progenitor 
cells that readily differentiate into osteoblasts to generate new bone. A subset of progenitors in 
the cambium layer are also known to form the fracture callus and bone in response to 
fracture53,54. These cells can differentiate into both osteoblasts and chondrocytes and are 
therefore called osteochondroprogenitors (OCPs).  
 
1.2 Mechanotransduction  
Mechanotransduction is the process by which cells sense physical stimuli and convert these 
mechanical signals into biochemical changes within the cell. Mechanical forces are critical to 
normal cell function and directly influence the formation and behavior of almost all tissues, 
spanning every stage of life and length scale. In fact, changes in tissue mechanical properties and 
the cell’s inability to engage in mechanotransduction are known to cause osteoporosis55, 
cancer56, cilium-specific diseases called ciliopathies57, and a variety of other diseases. Anything 
that responds to physical stimuli is called a mechanosensor or is known to be mechanosensitive. 
Cells that generate a measurable response to mechanotransduction are termed 
mechanotransducers.   
 
1.3 Second Messengers 
Second messengers are molecules that relay chemical and mechanical signals received at the 
cell surface and trigger signaling cascades within the cell. Two second messengers that are 
commonly studied in the context of mechanotransduction are calcium (Ca2+) and cyclic 
adenosine monophosphate (cAMP). Ca2+ is an extremely versatile molecule involved in a variety 
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of intracellular signaling pathways that encourage cell proliferation, transcription activation, and 
self-regulation of Ca2+ signalling58. Ca2+ may enter the cell due to changes in chemical gradients 
across the plasma membrane, as well as opening of stretch activated ion channels. The 
endoplasmic reticulum in the cell is also known to release internal stores of Ca2+ in response to 
mechanical and chemical stimulation. Studies from our lab and others suggest Ca2+ enters the 
primary cilium in response to fluid shear36,59,60 and is critical to its role in mechanosensation36,60–
63. Cyclic AMP is catalyzed from adenosine triphosphate (ATP)—which is commonly referred to 
as the “energy currency of the cell”64—by members of the adenylyl cyclase family. cAMP 
triggers intracellular signaling by activating protein kinase A (PKA), a phosphorylating enzyme 
known to be involved in osteogenesis65, and exchange proteins independent of the PKA 
pathway66. Our lab recently determined that fluid flow-induced changes in cAMP production are 
crucial to the osteocyte’s osteogenic response to physical stimulation35.   
Both Ca2+ and cAMP are tightly regulated spatially and temporally to effectively initiate 
intracellular signaling. The ability to tune the spatial and temporal release of these second 
messengers is critical to understanding how cell behavior can be manipulated on the molecular 
level and has become a popular topic of study. We propose that Ca2+/ cAMP dynamics are 
intimately coordinated in bone signaling cells (osteocytes) and study a potential mechanism that 
links them together in Chapter 4 of this thesis.   
 
1.4 Primary Cilia 
Structure and function 
The primary cilium is a solitary, non-motile organelle that is found in nearly all 
mammalian cell types. The ciliary base anchors the structure to the cell membrane and is 
9 
 
responsible for providing support, as well as managing entry of proteins and molecules into the 
cilium body. The portion of the cilium that projects from the cell surface is known as the 
axoneme and is composed of nine microtubule doublets (Figure 1.1) surrounded by a ciliary 
membrane, which is distinct from and not continuous with the plasma membrane. Cilia are 
approximately 250 nm in diameter and generally 1-4 µm long67, and therefore very small 
compared to the cell body. The axoneme is formed and maintained via intraflagellar transport 
(IFT), a process that requires the motor complex protein, IFT88, and KIF3A, an essential 
component of the anterograde motor protein, Kinesin-268. In the absence of IFT88 and KIF3A, 
the cilium cannot form69 or is unable to engage in mechanotransduction35,37,68. Murine animal 
models have been developed to disrupt primary cilia and study its effects in vivo. In fact, mice 
containing osteoblasts that lack KIF3A form significantly less bone in response to mechanical 
stimulation37 and some of our recent work shows a similar trend in mice lacking IFT88 in 
osteocytes/ osteoblasts. 
Once believed to be a vestigial structure, the primary cilium has since been identified as a 
crucial sensory organelle involved in chemosensing and mechanotransduction. In fact, a series of 
health complications spanning multiple tissues are directly associated with defects in the 
formation and function of cilia and its associated components. These diseases and disorders are 
called ciliopathies and result in skeletal deficiencies, developmental abnormalities, and cyst 
formation, among a variety of other issues57. The cilium possesses an extracellular component 
(axoneme), channels for transduction, and an intracellular connection, which are three general 
features associated with mechanotransduction70. Specifically, the cilium’s axoneme serves as the 
extracellular component, projecting from the cell surface to receive chemical signals and 
exposure to physical stimuli. The axoneme and base of the cilium contain ion channels and 
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transmembrane proteins that further engage in mechanotransduction. Physical bending of the 
cilium results in an influx of Ca2+36,71 and changes in cAMP35, which trigger intracellular 
signaling cascades. Due to its sensory nature, the cilium has been referred to as an antenna-like, 
amplifying signaling nexus72; however, the exact mechanisms for cilium mechanotransduction 
have yet to be uncovered, particularly in the context of bone.  
 
 
Figure 1.1: Structure of the primary cilium 
The primary cilium is composed of nine microtubule doublets in a 9+0 configuration depicted in the axoneme cross 
section. The axoneme is anchored to the cell via the basal body and surrounded by a distinct ciliary membrane. The 
ciliary membrane is not continuous with the cell’s plasma membrane, creating a ciliary pocket. The transition zone 
in the ciliary pocket functions as a filter, allowing only certain ciliary proteins to enter the axoneme. The axoneme is 
assembled and maintained via intraflagellar transport (IFT), whereby Kinesin-2 delivers IFT cargo, including IFT88, 




Proteins associated with the cilium   
In addition to serving as a mechanosensing organelle, the primary cilium is associated 
with a variety of proteins that further enhance mechanotransduction. These proteins consist of 
stretch-activated ion channels, receptors, and transmembrane proteins that can directly interact 
with external stimuli. Although some proteins are unique to the primary cilium, many are 
expressed elsewhere in the cell but concentrated in the cilium. Disruptions in some of these 
proteins alone have been directly tied to ciliopathies73,74. One hypothesis is that many of these 
proteins localize at the base of the cilium such that bending easily triggers their activation72. For 
this reason, it is believed that the cilium acts as a signal amplifier since it can convert small 
physical movements into large scale intracellular signaling cascades72. We highlight two of the 
ciliary proteins important for mechanotransduction below. 
TRPV4 
One ion channel believed to be associated with osteocytes is Transient Receptor Potential 
Vanilloid 4 (TRPV4). This Ca2+ ion channel is believed to open from chemical gradients, heat, 
physical stretching of the cell membrane, and binding of external Ca2+75,76. TRPV4 was first 
proposed to be involved in osteocyte cilium-mediated mechanotransduction when the Polycystin 
1 and Polycystin 2 complex (PC1/PC2)—known to be responsible for Ca2+ influx in kidney 
cells63—was not influential in osteocytes36. Specifically, an siRNA-mediated knockdown of 
TRPV4 hindered osteocyte mechanotransduction in vitro, whereas there was no effect with a 
PC2 knockdown36. Furthermore, disrupting TRPV4's ability to bind Ca2+ disables the subsequent 
Ca2+ influx76 and attenuates osteoclast activation and differentiation77,78. For these reasons, we 
investigate the effects of overexpressing TRPV4 and eliminating its ability to bind Ca2+ in the 




There are 10 isoforms of adenylyl cyclase (AC), which catalyze the conversion of ATP to 
cAMP, an aforementioned important second messenger for mechanotransduction. The first nine 
isoforms (AC1 - AC9) are transmembrane proteins, while AC10 is soluble79. All isoforms are 
activated by Forskolin to produce cAMP, but others bind Ca2+ to modify their behavior. 
Specifically, AC5 and AC6 are inhibited and AC1, AC3, and AC8 are activated when bound to 
Ca2+80. AC6 was discovered in the osteocyte cilium almost a decade ago and in vitro studies 
suggest the osteocyte's mechanically-induced osteogenic response is hindered when AC6 is 
knocked down35. Furthermore, mice containing a global knockout of AC6 form significantly less 
bone in response to mechanical stimulation48. Recent unpublished work in our lab suggests AC3 
is also present in the cilium, but its role in osteocyte mechanotransduction has yet to be explored. 
Furthermore, it is unknown whether AC6 and AC3 binding to Ca2+, a critical second messenger 
in mechanotransduction, serves as a link between osteocyte ciliary Ca2+ influx36 and subsequent 
changes in cytosolic cAMP35. Consequently, we seek to identify a Ca2+/cAMP complex that is 
mediated by ACs and potentially unique to the osteocyte primary cilium in Chapter 4. 
 
1.5 Postnatal growth plate 
The growth plate is a cartilaginous structure densely populated with chondrocytes that 
undergo a program of activation and differentiation to generate bone via endochondral 
ossification. The growth plates form shortly after birth in the epiphyses and are responsible for 
lengthening of the arm and leg bones. The growth plate contains four distinct regions termed 
zones that are determined by observing chondrocyte morphology: resting, proliferation, 
hypertrophic, and ossification zones (Figure 1.2). The resting zone is characterized by round 
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chondrocytes, which then flatten and align into vertical columns as they rapidly undergo mitosis 
in the proliferation zone. The hypertrophic zone contains expanded, cuboidal chondrocytes that 
express type X collagen. These cells then undergo apoptosis or become osteoblasts46 to aid in 
forming mineralized matrix and, eventually, bone in the ossification zone. The size of the growth 
plate, proliferation zone, and hypertrophic zone are critical to the rate and extent of longitudinal 
bone growth81. Additionally, the onset and rate of hypertrophic differentiation is particularly 
critical for chondrocytes to undergo the normal program of endochondral ossification. The 
primary cilium protein IFT88 has been implicated in chondrocyte proliferation and 
differentiation during skeletal development 47,82, so we study the role of the primary cilium itself 
in postnatal limb development in Chapter 3. 
 
 
Figure 1.2: Structure of the postnatal growth plate 
Hematoxylin and eosin stain of a murine ulnar growth plate at postnatal day 21 (P21). The growth plate is organized 
into four specific zones from the distal (top) to proximal end: resting zone, proliferation zone, hypertrophic zone, 
and ossification zone. In some instances, the region where proliferating cells begin to undergo hypertrophy is 
referred to as the pre-hypertrophic zone. Micrograph was collected with an inverted microscope (Olympus CKX41) 
at 20X.  
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Chapter 2: Periosteal osteochondroprogenitors are 
mechanosensitive and necessary for adult bone formation 
 
Abstract 
 The fully developed adult skeleton adapts to mechanical forces by generating more bone, 
usually at the periosteal surface. Progenitor cells in the periosteum are believed to differentiate 
into bone-forming osteoblasts that contribute to load-induced adult bone formation, but in vivo 
evidence does not yet exist. Furthermore, the mechanism by which periosteal progenitors might 
sense physical loading and trigger differentiation is unknown. We propose that periosteal 
progenitors directly sense mechanical load and differentiate into bone-forming osteoblasts via 
their primary cilia, mechanosensory organelles known to be involved in osteogenic 
differentiation. We generated an ablation model to quantify the contribution of periosteal 
osteochondroprogenitors (OCPs) in adult bone formation in vivo. Indeed, mice lacking periosteal 
OCPs had severely attenuated mechanically induced bone formation and lacked mineralization 
necessary for daily skeletal maintenance. We also generated a cilium knockout model to study 
the primary cilium’s role in periosteal OCP mechanosensing in vitro. Our results demonstrate 
that periosteal OCPs directly sense fluid shear and exhibit an upregulation in osteogenic markers; 
however, this response is essentially lost when the primary cilium is absent. Combined, our data 
show that periosteal progenitors are a mechanosensitive cell source that significantly contributes 
to load-induced adult bone formation. More importantly, this population persists in the adult 
skeleton and these cells, as well as their cilia, are promising targets for bone regeneration 




One way the skeleton structurally adapts to its mechanical environment is by generating 
new bone to alter its geometry and density to better withstand higher forces. Bone formation in 
response to mechanical loading involves multiple cell types and requires a sequence of events to 
occur. Specifically, mechanosensitive osteocytes sense physical loading and secrete paracrine 
factors that recruit cells to the bone surface83. These cells eventually transform into matrix-
producing osteoblasts and, potentially, embedded osteocytes. With innovative regenerative bone 
therapies rapidly emerging, it is more important than ever to determine the origin of cells 
recruited to the bone surface. Bone-forming cells have long been thought to originate from 
progenitors, so approaches were developed to extract osteoblast precursors from bone marrow; 
however, these procedures are very invasive and the acquired progenitors require further 
treatment to encourage differentiation. An appealing alternative is to harvest periosteum, which 
surrounds bones and is rich in progenitor cells known to preferentially differentiate toward the 
osteogenic lineage53,84,85.  
Intriguingly, previous in vitro studies suggest that progenitor cells directly sense physical 
stimulation, which in turn enhances differentiation towards the osteogenic lineage39,86. In 
addition, mechanical forces on the periosteum are also known to enhance osteogenic lineage 
commitment in vivo and in vitro.  Henderson et al. observed localization of cells with osteogenic 
gene expression to areas of tension on the outer edges of embryonic mouse rudiment tissues87 
and Kanno et al. found osteogenic markers were upregulated when mechanical strain was applied 
to human periosteal cells88. Although these in vitro studies are promising, it remains unknown 
whether progenitors within the periosteum directly sense mechanical stimulation and/ or respond 
in an osteogenic manner.   
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Many in vivo studies have successfully used a loading regimen to quantify how quickly 
new bone is laid down by osteoblasts37,89,90, but fail to characterize the roles of progenitor cells in 
the normal program of adult bone formation.  Furthermore, these studies typically report bone 
formation rates for only the periosteal region, which, due to geometry, experiences amplified 
mechanical signals compared to the endocortical region. A recent study suggests the periosteal 
surface is less mechanoresponsive than the endocortical surface and that the load-induced 
periosteal response decreases with age91. This contradicts prior claims that periosteal progenitor 
activity does not vary with age33. Thus, it is important to determine the extent to which periosteal 
progenitors contribute to adult bone formation and identify how they might sense and respond to 
mechanical cues in vivo. For these reasons, we quantify the amount of bone formed in skeletally 
mature mice without periosteal progenitors and investigate the mechanism by which these 
progenitors recognize and respond to mechanical loading. 
One potential mechanism by which progenitor cells may become mechanically activated 
is through the primary cilium.  Primary cilia are antenna-like organelles that extend from the cell 
surface and serve as amplifying microdomains to enhance interactions between external stimuli 
and intracellular signaling molecules. Impairment of primary cilia formation and signaling is 
known to influence bone development and formation37,48,92,93. A prior study conducted in our lab 
revealed that load-induced bone formation was attenuated when an intraflagellar retrograde 
transport protein important for primary cilia function (Kif3a) was deleted in osteoblasts and 
osteocytes37. Our previous work also suggests cilia are critical to osteogenic differentiation of 
periosteal progenitors84,86, as well as human mesenchymal stem cells39,94, in vitro. Furthermore, 
we recently determined that mechanical loading activates progenitors to form bone in adults but 
this response is attenuated when their cilia are disrupted167. Despite the clear implications, how 
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periosteal progenitor cell primary cilia mediate the in vivo bone formation response to 
mechanical stimulation has yet to be investigated.  
Prx1 is expressed in the inner layer of the periosteum in close association with cortical 
bone and is deemed a marker for osteochondroprogenitors (OCPs), or cells that preferentially 
differentiate into osteoblast and chondrocytes53.  In adult animals, Prx1-expressing cells are 
restricted to the appendicular skeleton and populate the fracture callus53 and cortical bone167. Our 
prior work suggests that Prx1-expressing cells found embedded in bone in response to 
mechanical loading are perhaps periosteum-derived; however, Prx1’s specific expression 
patterns have yet to be determined in the skeletally mature adult. Progenitor cells generally 
demonstrate upregulation in osteogenic markers when subjected to physical stimuli in 
vitro39,40,88, so it is possible that progenitors residing in the cambium layer generate bone in 
response to mechanical cues in vivo33,95–97. This hypothesis has yet to be tested since ubiquitous 
ablation of Prx1-expressing cells is embryonic lethal98. A recent tamoxifen-inducible 
Prx1CreER-GFP model53 has made it possible to study Prx1-expressing OCP ablation after birth 
and at specific timepoints of interest. Thus, this conditional transgenic model is perhaps a novel 
method for studying the unknown role of periosteal OCPs in normal adult physiology.  
The objectives of this study are three-fold. First, to determine Prx1 expression in the 
skeletally mature adult mouse using the GFP tag associated with our Prx1CreER-GFP model. 
Second, to quantify the contribution of Prx1-expressing OCPs in load-induced bone formation 
using a conditional diphtheria toxin A (DTA) ablation model. Finally, we seek to determine the 
mechanism by which primary cilia mediate the periosteal OCP’s potential osteogenic response to 




Materials and Methods 
Animal models 
All mouse models are on a C57BL6 background. Prx1CreER-GFP males were bred with 
Rosa26tdTomato females acquired from Jackson Laboratories to generate our Prx1CreER-GFP; 
Rosa26tdTomato(-/+) fluorescent reporter model. Prx1CreER-GFP females were bred with 
Rosa26DTA males acquired from Jackson Laboratories to generate Rosa26DTA(-/+) control and 
Prx1CreER-GFP; Rosa26DTA(-/+) experimental offspring. Animals used for the ulnar loading 
experiments did not participate in breeding. Prx1CreER-GFP males were bred with Ift88fl/fl 
females to generate Prx1CreER-GFP; Ift88fl/fl offspring for primary cell isolations. Genotype was 
determined using PCR and agarose gel electrophoresis. Primer sequences are available upon 
request. Animals were housed, maintained, and evaluated for health complications in accordance 
with IACUC standards. The Institute of Comparative Medicine at Columbia University approved 
all experiments. 
Tamoxifen injections 
Tamoxifen (Sigma Aldrich) was dissolved in corn oil (Sigma Aldrich) in a shaking 
incubator at 37°C to create a 25 mg/mL stock solution stored at 4°C and protected from light. 
Tamoxifen solution was prepared fresh for each series of loading experiments. Skeletally mature 
16 week-old adult Prx1CreER-GFP; Rosa26tdTomato mice received a single intraperitoneal 
injection of 100 mg/kg body weight tamoxifen. Adult Prx1CreER-GFP; Rosa26DTA experimental 
and Rosa26DTA controls received daily intraperitoneal injections of 75 mg/kg tamoxifen solution 
for five days prior to loading, concurrent with the 3 days of loading, and concurrent with 
fluorochrome label injections after loading.  
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In vivo ulnar loading 
Skeletally mature 16-week-old mice were placed under isofluorane anesthesia and the 
right forelimbs were anchored between 2 platens attached to an electromagnetic loading system 
with feedback control (Bose Enduratec ELF 3220). Following an initial 0.1 N load, a peak 
compressive axial load of 3 N was applied with a 2 Hz sine wave for 120 cycles/day for 3 
consecutive days. The non-loaded left forelimbs served as internal controls. Body weight was 
measured each time an injection or ulnar loading was administered and cage activity and 
anesthesia recovery time were observed to monitor animal health. Mice received subcutaneous 
injections of 10 mg/kg calcein (Sigma Aldrich) and 70 mg/kg alizarin red (Sigma-Aldrich) 5 and 
9 days following initiation of loading, respectively. All animals were euthanized 15 days after 
the initiation of loading and prepared for analysis. 
Micro-computed tomography (microCT) and dynamic histomorphometric analysis 
Upon sacrifice, loaded and non-loaded ulnae were dissected and stored in 70% ethanol 
for up to a week. The non-loaded limb of each specimen was imaged by microCT (Scanco 
vivaCT 80, Scanco Medical AG) at 10.4 µm isotropic resolution using scan settings of 55 kV, 
145 µA, and 300 ms integration time. Bone lengths were determined from scout views. Cortical 
bone analyses were performed at the mid diaphysis of each ulna and Scanco analysis software 
was used to determine total bone area, the ratio of bone volume to total volume (BV/TV), bone 
mineral density (BMD), cortical thickness, the polar moment of inertia (pMOI), and the 
minimum and maximum second moments of inertia (Imin and Imax).   
Following the microCT scan, ulnae were gradually dehydrated in a tissue processor 
(Leica ASP300S), infiltrated with methyl methacrylate, and embedded in methyl methacrylate 
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and benzoyl peroxide (Sigma Aldrich), as described previously37. Embedded specimens were 
sectioned at the ulnar midshaft using a diamond-tip blade and saw (Isomet) and transverse 
sections were imaged on a confocal microscope (Olympus Fluoview). The bone surface, single 
label, and double label perimeters and double label area were quantified in ImageJ in order to 
calculate mineralizing surface/bone surface (MS/BS), mineral apposition rate (MAR), and bone 
formation rate/bone surface (BFR/BS)37,99. All measurements were taken from the periosteal 
surface. Non-loaded ulnae values were subtracted from loaded values to determine relative 
measurements of rMS/BS, rMAR, and rBFR/BS, which represent changes due to mechanical 
loading. 
Histology 
Upon sacrifice, ulnae were dissected and fixed overnight at 4°C. For histological 
analysis, specimens were fixed in 10% formalin (Sigma Aldrich), decalcified, embedded in 
paraffin, sectioned in 5 µm increments, and stained with Hematoxylin and Eosin (Sigma Aldrich) 
for 10 minutes and 30 seconds, respectively. Micrographs were collected with an inverted 
microscope (Olympus CKX41) at 20X magnification. To determine whether our ablation model 
was successful, ulnae were fixed in 4% paraformaldehyde (Sigma Aldrich), decalcified, and 
cryosectioned in 5 µm increments. Micrographs were collected with a confocal microscope 
(Olympus Fluoview) at 100X magnification.  
Primary periosteal OCP isolation 
Prx1CreER-GFP and Prx1CreER-GFP; Ift88fl/fl juveniles were sacrificed between 3 and 4 
weeks of age and their fore and hindlimbs were collected for dissections. The skin, fascia, 
connective tissue, and majority of the muscle surrounding the periosteum were removed using a 
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scalpel and the specimens were placed in sterile PBS (Life Technologies) on ice. The epiphyses 
were then cut off, the remaining muscle surrounding the periosteum was removed, and the 
specimens were transferred to fresh cold PBS. In a sterile culture hood, the periosteum was 
scored with a scalpel, peeled off the bone, cut into 1 mm2 sections, and placed into fibronectin 
(Sigma Aldrich) coated tissue culture dishes containing MEMα (Life Technologies) 
supplemented with 10% FBS and 1% P/S (Life Technologies). Tissue sections were incubated at 
37°C for 7 – 10 days and the resulting primary periosteal cells were passaged onto fresh 
fibronectin coated tissue culture dishes and cultured until reaching 80% confluence. 
Immunocytochemistry 
 To visualize cilia, cells were rinsed with cold PBS and fixed in 10% formalin solution 
(Sigma) for 10 min, then blocked in 10% goat serum for 1 hour at room temperature. Blocked 
cells were incubated in a 1:10 dilution of primary anti-acetylated α-tubulin antibody isolated 
from a C3B9 hybridoma line (Sigma), followed by a 1:500 dilution of the fluorescent secondary 
antibody AlexaFluor 568. Both incubations were for 1 hour at room temperature. Nuclei were 
detected using NucBlue ReadyProbes (Life). Fluorescent images were collected using an 
Olympus Fluoview FV1000 confocal microscope and software.   
Cell culture and sorting 
Primary periosteal cells were cultured on fibronectin coated dishes in MEMα 
supplemented with 10% FBS and 1% P/S at 37°C. An Influx cell sorter (BD Biosciences) was 
used to separate cambium layer osteochondroprogenitors (GFP+) from other cells of the 
periosteum (GFP-). Sorted cells were cultured for 1 – 2 weeks until a sufficient number of cells 
were available for flow studies. Passages P2 – P4 were used for all in vitro experiments.  
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Oscillatory fluid flow (OFF)   
To test the effects of direct mechanical stimulation on periosteal cells, Prx1-expressing 
osteochondroprogenitors (GFP+) and other cells of the periosteum (GFP-) were seeded on 
fibronectin coated glass slides (Fisher Scientific; 75 x 38 x 1 mm) and cultured in reduced serum 
media (MEMα supplemented with 2.5% FBS, 2.5% CS, and 0.5% P/S) 48 hours prior to fluid 
flow. To disrupt primary cilia, cells were treated with (Z)-4-Hydroxytamoxifen (Sigma Aldrich) 
diluted to 5 µg/mL in 95% ethanol or vehicle control 24 hours prior to flow. Upon reaching 80% 
confluence, cells were placed in parallel-plate flow chambers (56  ×  24  ×  0.28 mm), incubated at 
37°C for 30 minutes at rest, and exposed to 60 minutes of oscillatory fluid flow (OFF) at 1 Hz 
with a peak shear stress of 10 dyn/cm2. Slides were removed from the chambers and lysed 
immediately with TriReagent (Sigma Aldrich) to isolate RNA. RT-qPCR was performed to 
quantify flow-induced changes in Cyclooxygenase-2 (COX-2), Osteopontin (OPN), and GAPDH 
using fluorescent primers (Life Technologies) and an ABI PRISM 7900 (Applied Biosystems). 
Samples were performed in triplicate and COX-2 and OPN were normalized to GAPDH 
expression levels. OFF samples were normalized to static controls.  
Statistics 
No sex-dependent differences were identified in our dynamic histomorphometric analysis 
according to a 2-way ANOVA, so males and females were grouped together for the ulnar loading 
experiment results. All data were analyzed with a two-tailed student’s t-test and values are 
reported as mean ± SEM, with p < 0.05 considered statistically significant. Sample size was 





Successful generation of mouse models 
PCR and gel electrophoresis confirmed that we generated Prx1CreER-GFP; Rosa26DTA 
and Rosa26DTA littermates, as well as Prx1CreER-GFP; Rosa26tdTomato reporter mice (Figure 2.2). 
When Prx1CreER-GFP; Rosa26DTA animals are injected with tamoxifen, Prx1-expressing cells 
will produce diphtheria toxin A, causing periosteal OCPs to be ablated. Similarly, Prx1-
expressing cells and their progeny will produce red fluorescent protein in Prx1CreER-GFP; 
Rosa26tdTomato mice.  
 
Figure 2.1: Prx1-driven OCP ablation and red fluorescent reporter models were generated 
Gel electrophoresis confirmed Prx1CreER-GFP animals were successfully crossed with (a) Rosa26DTA mice to 
generate a conditional periosteal osteochondroprogenitor ablation model (Prx1CreER-GFP; Rosa26DTA) and (b) 
Rosa26tdTomato animals to produce a Prx1CreER-GFP; Rosa26tdTomato fluorescent reporter model.  
 
 
Prx1 expression is restricted to the periosteum in adult ulnae 
 Skeletally mature 16-week old fluorescent reporter mice (Prx1CreER-GFP; 
Rosa26tdTomato) were injected with a single dose of tamoxifen to determine the location of Prx1-
expressing cells and confirm Cre activity. Indeed, red fluorescent cells were present, indicating 
successful Cre recombination. We found recombined cells in the ulnar periosteum (Figure 2.1) 
and perichondrium (not pictured), but these cells were absent from cortical bone, trabecular 
24 
 
bone, muscle, and marrow. We therefore conclude the Prx1CreER-GFP model is an appropriate 
tool for determining the effects of periosteal OCP ablation on load-induced adult bone formation.  
Tamoxifen treatment ablates periosteal OCPs in vivo and disrupts their cilia in vitro  
 We visualized GFP expression to determine whether Prx1-expressing OCPs were present 
in the periosteal tissue of Prx1CreER-GFP; Rosa26DTA mutants and Prx1CreER-GFP controls 
injected with tamoxifen. Indeed, mutants (Figure 2.3b) lacked the green fluorescent Prx1- 
expressing cells observed in control periosteum (Figure 2.3a), indicating tamoxifen-induced Cre 
recombination successfully ablated the periosteal OCP population of interest in vivo. Primary 
periosteal OCPs obtained from Prx1CreER-GFP; Ift88fl/fl animals were sorted via GFP and 
treated with 4-hydroxytamoxifen, the active compound of tamoxifen that is generated when 
 
Figure 2.2: Prx1 expression is restricted to the periosteum in the adult ulnae  
Skeletally mature 16-week-old Prx1CreER-GFP; Rosa26tdTomatomice received a single dose of tamoxifen to induce 
Cre recombination and, subsequently, red fluorescent protein production, and were sacrificed a week later. 
Recombined cells were found in the periosteal tissue but were absent from cortical bone, trabecular bone, muscle, 












































Figure 2.3: Tamoxifen successfully activates Cre recombination in our animal models in 
vivo and in vitro 
Prx1-expressing cells (green) were observed in the periosteum of Prx1CreER-GFP; Rosa26DTA animals not exposed 
to tamoxifen (a). Prx1CreER-GFP; Rosa26DTA animals injected with 100 mg/kg tamoxifen (b) no longer contain 
these periosteal OCPs. Primary OCPs obtained from Prx1CreER-GFP; Ift88fl/fl animals (c) normally contain primary 
cilia (red); however, the presence and length of these cilia are diminished when exposed to 5 µM 4-
hydroxytamoxifen (d). Indeed, cells treated with tamoxifen have decreased Ift88 mRNA expression (e). 
Micrographs of the periosteum and isolated cells were collected at 20X and 40X, respectively. Nuclei are displayed 
in blue. Scale bars indicate 50 µm. Data reported as mean and standard error. n = 4 for each group, ***p < 0.0001. 
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tamoxifen is introduced into animals in vivo. Cells treated with 4-hydroxytamoxifen (Figure 
2.3d) demonstrated shorter and fewer cilia compared to vehicle controls (Figure 2.3c), 
confirming that this treatment successfully disrupted primary in vitro.   
 
Table 2.1 Ulna cortical bone properties 
 Data are presented as the mean ± standard error 
 
Mice lacking periosteal osteochondroprogenitors have severely attenuated load-induced 
bone formation 
Genetic modifications may alter bone structure in transgenic animals, resulting in 
changes that influence the skeleton’s response to load. To ensure that our ablation model did not 
alter bone properties, which would introduce a confounding variable in our compressive ulnar 





     Control             Prx1 Ablation 
Male 
 











Bone Area (mm2) 0.281 ± 0.012 0.263 ± 0.018 0.294 ± 0.005 0.295 ± 0.006 
Cortical Thickness (mm) 0.172 ± 0.001 0.169 ± 0.004 0.169 ± 0.004 0.175 ± 0.002 
BV/TV  0.867 ± 0.002 0.864 ± 0.003 0.863 ± 0.002 0.863 ± 0.001 
BMD (mg HA/ ccm) 1293 ± 5.3 1289 ± 5.2 1282 ± 3.3 1288 ± 7.0 
pMOI (mm4) 0.024 ± 0.003 0.020 ± 0.003 0.027 ± 0.001 0.027 ± 0.001 
Imax (mm4) 0.019 ± 0.003 0.016 ± 0.003 0.022 ± 0.001 0.023 ± 0.001 
Imin (mm4) 0.0043 ± 0.0004 0.0040 ± 0.0005 0.0048 ± 0.0004 0.0040 ± 0.0002 
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Rosa26DTA animals using micro-computed tomography (µCT). We did not identify any 
differences in bone microstructure (Table 2.1); therefore, all of our loading experiment results 
are specifically due to periosteal OCP ablation.  
H&E stains were then performed to visualize bone tissue in the loaded ulna of animals 
with and without periosteal OCPs (Figure 2.4). Interestingly, the periosteum was often thinner in 
the ablation model, perhaps due to loss of progenitors in the cambium layer. We initially noticed 
this trend when we observed GFP expression following ablation (Figure 2.3a,b) and noted that 
the periosteum was often thinner when GFP+ cells were absent. We also identified periosteal 
cells differentiating into osteoblasts to lay down new matrix in response to load (Figure 2.4c) but 




















Figure 2.4: OCP ablation results in a thinner periosteum and a lack of load-induced 
osteoblast differentiation 
Hematoxylin and eosin stains of tissue sections from control (a,c) and experimental animals (b,d). Loaded ulnae 
(c,d) were compared to non-loaded contralateral controls (a,b). Periosteum thickness is denoted with black arrows. 
The black box in (c) highlights periosteal cells differentiating into osteoblasts. Micrographs were collected at 20X 




Figure 2.5: Mineralization and load-induced bone formation are severely attenuated in 
mice lacking OCPs 
Dynamic histomorphometry of Rosa26DTA control and Prx1CreER-GFP; Rosa26DTA ablation animals. Mice lacking 
periosteal OCPs demonstrate poor mineralization, indicated by calcein (green) and alizarin (red) fluorochrome labels 
(a), and attenuated bone formation due to a limited mineralizing surface and mineral apposition rate (b). Loaded 
ulnae were normalized to non-loaded limbs. Data reported as mean and standard error. n = 16, ***p < 0.0001. 
Micrographs collected at 10X.  
 
We visualized calcein and alizarin fluorochrome labels to assess mineralization with 
standard cage activity and in response to load. Control animals demonstrated some 
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mineralization in the non-loaded limb and, as expected, the mineralizing surface was greater in 
response to load (Figure 2.5a). We also observed a distinct gap between the alizarin and calcein 
labels in loaded control animals, indicating newly formed bone. In contrast, ablation animals 
demonstrated almost no mineralization under non-loaded conditions and a weak increase in 
response to load, suggesting very little bone was formed under static and loaded conditions. We 
quantified our observations via dynamic histomorphometry and, indeed, mutants lacking OCPs 
have severely attenuated bone formation rate (Figure 2.5b), making this the most severe 
disruption our lab has witnessed in our history of dynamic histomorphometry studies37,48. 
 
Periosteal OCPs respond to mechanical stimulation in a primary cilium-dependent manner 
Although periosteal tissue100 and calvaria periosteal osteoprogenitors101 respond to 
physical stimulation, it is unknown whether osteochondroprogenitors in long bone periosteal 
tissue are mechanoresponsive. We therefore isolated cells from murine tibial periosteum and 
exposed them to oscillatory fluid flow (OFF) to determine if these cells respond to mechanical 
stimulation. Furthermore, we separated periosteal Prx1-expressing OCPs from the other cells of 
the periosteum to evaluate whether this population has a greater osteogenic response to physical 
stimuli. Indeed, both the sorted OCPs and other cells of the periosteum exposed to OFF exhibited 
increased Cyclooxygenase-2 (COX-2) mRNA production compared to static controls (Figure 
2.6a), indicating an inflammatory response that signifies a cellular reaction to stimulation. 
Interestingly, only Prx1-expressing OCPs demonstrated a flow-induced increase in Osteopontin 
(OPN), a marker for osteogenesis (Figure 2.6b). In fact, Prx1-expressing OCPs had significantly 
higher levels of OPN than other cells of the periosteum under static conditions, suggesting this 
periosteal OCP population is inherently more osteogenic. Periosteal OCPs also exhibited 
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significantly greater fold changes in COX-2 and OPN expression compared to other cells of the 
periosteum (Figure 2.6c), indicating OCPs are more responsive to mechanical stimulation. 
 
 
Figure 2.6 Periosteal OCPs uniquely respond to mechanical stimulation in an osteogenic 
manner 
Periosteal cells isolated from 3-week-old Prx1CreER-GFP mice were exposed to 1 hour of oscillatory fluid flow 
(OFF) and changes in mRNA expression were quantified via RT-qPCR. Prx1-expressing osteochondroprogenitors 
(OCPs, green) demonstrated flow-induced increases in COX-2 (a) and OPN expression (b), whereas other cells of 
the periosteum (red) were nonresponsive. Additionally, the fold changes in COX-2 (c) and OPN (d) expression were 
significantly higher for OCPs compared to other cells of the periosteum. Data reported as mean and standard error. 
Other NF n = 5, Other F n = 7, OCPs NF and F n = 6, *p < 0.01, ***p < 0.0001. 
 
We then examined whether this osteogenic response to flow was mediated by the primary 
cilium. Indeed, primary periosteal OCPs isolated from Prx1CreER-GFP; Ift88fl/fl animals that 
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were treated with tamoxifen had an abrogated response to OFF. Specifically, periosteal OCPs 
containing a tamoxifen-induced Ift88 knockout to disrupt primary cilia formation demonstrated 
significantly lower flow-induced increases in COX-2 and OPN expression compared to vehicle 
controls (Figure 2.7). This suggests that primary cilia are necessary for CLOPs to a) sense 
mechanical stimulation and b) respond to fluid shear in an osteogenic fashion.  
 
Figure 2.7 OCP primary cilia are necessary for the flow-induced osteogenic response 
Periosteal OCPs isolated from 3-week-old Prx1CreER-GFP; Ift88fl/fl mice were exposed to 1 hour of oscillatory 
fluid flow (OFF) and changes in mRNA expression were quantified via RT-qPCR. Vehicle control OCPs (white 
bars) demonstrated flow-induced increases in the fold changes of COX-2 (a) and OPN expression (b). This effect 
was lost in OCPs treated with tamoxifen (gray bars) to disrupt primary cilia formation. Data reported as mean and 
standard error. Vehicle n = 6, Tamoxifen n = 5, ***p < 0.0001. 
 
Discussion 
Despite its ubiquity in embryonic development, Prx1 expression is restricted to a unique 
osteochondroprogenitor cell population in the adult forelimb. Prx1 expression is rampant in the 
mesenchymal limb bud and has been incompletely characterized after birth53, so we utilized our 
Prx1CreER-GFP; Rosa26tdTomato reporter to identify cells that express Prx1 in the forelimbs of 
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skeletally mature adults. The vast majority of labeled cells were found in the periosteum, with 
some present in the perichondrium and shoulder tendon. Furthermore, these cells were only 
present in the inner cambium layer of the periosteum, which is known to readily provide 
osteogenic precursors that participate in osteogenesis. The perichondrial expression may be 
unique to mice since their epiphyseal growth plates do not seal like those in other animals and 
humans. Due to physical distance alone, it is highly unlikely that cells from the perichondrium or 
shoulder tendon would contribute to bone formation in the midshaft of the diaphysis; thus, we 
are confident that our Prx1 model is an excellent tool for studying the role of periosteal OCPs in 
load-induced bone formation. Additionally, the presence of Prx1 in adults is an exciting finding 
because it indicates this OCP population remains active with age.  Kawanami et al. previously 
determined that Prx1-expressing cells populate the fracture callus in response to trauma53, but it 
was previously unknown whether this population existed under static physiological conditions. 
Progenitor activity and presence is often negatively correlated with increasing age, but these 
common drawbacks perhaps do not apply to the periosteal Prx1-expressing OCP population. 
Prx1-expressing cells isolated from the periosteum readily and specifically differentiate into 
osteoblasts and chondrocytes in vitro and therefore have been characterized as 
osteochondroprogenitors53,54. Thus, this Prx1 promoter can be used to study a unique adult 
periosteal OCP cell population.  
Periosteal cells have long been thought to participate in load-induced bone formation, but 
our work is the first to demonstrate and quantify this contribution. Our dynamic 
histomorphometry reveals that Prx1-expressing OCPs in the periosteum not only contribute to 
bone formation, but they are perhaps the primary source of osteoblasts in load-induced 
adaptation. The complete ablation of Prx1-expressing periosteal OCPs is the most severe 
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disruption our lab has witnessed in the history of our dynamic histomorphometry work37,48. This 
is potentially because former disruptions were cilium-specific, but we initially had suspicions 
that ciliary disruptions could result in more severe attenuation. To clarify, cilium disruption 
affects only the cell’s ability to sense mechanical stimulation, whereas ablation eliminates the 
entire cell. When the entire cell is absent, repopulation or compensation from other progenitor 
sources are possible102,103, but these options are not available when cells lacking cilia persist. The 
nearly complete lack of mineralization in the non-loaded limbs suggests this progenitor source is 
required for daily skeletal maintenance, in addition to load-induced bone formation. The 
mineralization that does occur is likely due to bone lining cells, which are mature osteoblasts that 
line the periosteal surface and are a continuous source of osteoblasts in cortical bone50,51. 
Another possibility is that some OCPs remain due to incomplete Cre recombination, but we 
found that Prx1-expressing cells were totally ablated in vivo in our model (Figure 2.3b). With 
these observations, we now have a complete characterization of the Prx1-expressing cell 
population from embryonic development to adult adaptation. Specifically, Prx1-expressing 
progenitors contribute to the initial formation of the limbs98, postnatal endochondral and 
intramembranous ossification to completely develop the skeleton (Chapter 1), static and load-
induced adult periosteal bone formation, and fracture repair53. 
Periosteal progenitors have long been thought to be mechanosensitive, but this study 
demonstrates, for the first time, that periosteal Prx1-expressing OCPs directly sense loading. 
Periosteal cells are believed to differentiate into osteoblasts in vivo in response to physical 
stimulation. Indeed, in vitro studies demonstrate that primary periosteal cells readily differentiate 
into osteoblasts when conditioned media is applied84. We isolated the population of primary 
periosteal OCPs that was ablated in our ulnar loading studies and found that these cells not only 
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directly sense fluid shear, but upregulate mRNA expression of typical markers for osteogenesis. 
Interestingly, this osteogenic response to fluid shear is not present in other cells of the 
periosteum, suggesting this characteristic is unique to Prx1-expressing OCPs. Given that adult 
bone formation is severely attenuated when this mechanosensitive population is absent, we 
finally confirm a long-standing hypothesis that Prx1-expressing OCPs in the periosteum directly 
sense mechanical stimulation and differentiate into bone-forming osteoblasts during adult bone 
formation. 
Furthermore, we speculate that the primary cilium is the mechanism by which these 
progenitors participate in adult bone formation. We previously identified that load-induced bone 
formation was attenuated in animals lacking Prx1-expressing cell primary cilia167. Although we 
identified that the rate of mineralization was attenuated in mutant animals, the periosteal OCP 
primary cilium’s exact role during bone formation remains unclear. One possibility is that 
periosteal OCPs directly sense mechanical stimulation via their primary cilia and consequently 
differentiate into bone-forming osteoblasts. Indeed, we found that periosteal OCPs have an 
osteogenic response to physical stimulation that is abrogated when primary cilia are absent. We 
therefore propose that, during load-induced bone formation, periosteal OCP primary cilia 
directly sense loading and differentiate into osteoblasts that actively lay down new bone matrix.   
Primary OCPs are easily extracted from periosteal tissue and grown up in culture, 
suggesting they are an attractive source for tissue regeneration strategies. A typical isolation was 
performed with 6 – 8 mice and periosteal tissue was extracted from only the ulnae and tibiae. 
Cells adhered to the dish surface within 3 – 5 days and continued to migrate from tissue for as 
long as 2 weeks after the dissection. Within 3 weeks of the initial dissection, approximately 8 
million cells were available for sorting and, on average, only 3.3 ± 0.8% of those cells were 
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GFP+ Prx1-expressing OCPs. It is interesting that Prx1-expressing cells make up such a small 
percentage of the total cells in the periosteum, yet have such a drastic impact on adult bone 
formation and fracture repair. Despite the low percentage and some cell death due to sorting, 
these cells rapidly proliferate within 24 hours and we were able to generate enough cells for a 
typical fluid flow study (about 500k) in a matter of days. These cells continued to proliferate at 
the same rate and were passaged up to 10 times spanning 2 months after sorting. It is possible 
that the cells can be cultured for longer, but this was the maximum duration we tested due to 
available time and resources. The percentage of Prx1-expressing cells increased when given 
more time in culture before sorting, suggesting these cells proliferate at a higher rate than other 
cells of the periosteum. This extraction is faster or similar to the amount of time it takes to isolate 
primary mesenchymal stem cells (MSCs)104 and proliferation rates are comparable. MSCs 
require further guidance in vitro to differentiate into osteoblasts, whereas periosteal OCPs are 
pre-programmed towards an osteoblastic or chondrogenic lineage and therefore require less 
culture time53,54. Further work must be done to compare human periosteal OCPs and MSCs to get 
a definitive answer, but our results suggest that the periosteum is a promising source for 
osteogenic precursors in tissue regeneration applications.    
Collectively, our results motivate the use of periosteal Prx1-expressing OCPs and 
manipulation of their primary cilia for TERM applications. The field of Tissue Engineering and 
Regenerative Medicine involves using cells to restore damaged or unhealthy tissue, usually in 
combination with an engineered scaffold to deliver the cells to a region of interest. The current 
preferred method for bone regeneration is to seed MSCs that have been extracted and guided to 
an osteoblastic lineage in vitro33. However, periosteal progenitors are a promising candidate for 
bone tissue regeneration because they preferentially provide both osteoblasts and chondrocytes95. 
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Our studies demonstrate that periosteal OCPs are still prevalent and active in skeletally mature 
adults and can therefore be useful when extracted in older patients. This finding is consistent 
with studies that suggest periosteal progenitors consistently proliferate and function independent 
of age105–107. More importantly, we identified that periosteal OCPs are not only inherently 
involved in normal and load-induced adult bone formation, but are by far the main contributors 
to these phenomena. Similarly, Colnot et al. demonstrated that periosteum-derived progenitors 
are the most prevalent cell source in the fracture callus95. This suggests periosteal OCPs have a 
surprising ability to proliferate and generate new bone in vivo, even though they represent a mere 
3% of cells found in the periosteum. Additionally, OCPs are easier to extract and take less time 
to culture in vitro compared to MSCs. We also found that primary cilia are critical to the 
osteogenic nature of OCPs. These sensory organelles can be manipulated in vitro to enhance 
osteogenesis42 and preliminary work in our lab suggests this work can be translated in vivo. 
Overall, periosteal OCPs are perhaps the optimal source for bone TERM strategies since they are 
easy to extract and culture, supply osteoblasts and chondrocytes for both forms of ossification, 
function independent of age, and contain primary cilia that can be tuned to enhance OCP-






Chapter 3: Osteochondroprogenitors populate the postnatal 
skeleton and require primary cilia to participate in ossification 
 
Abstract 
Although Prx1-expressing osteochondroprogenitor cells and their primary cilia are 
critical for embryonic development, they have yet to be studied in the context of postnatal 
skeletogenesis due to the lethality of previous mouse models. A tamoxifen-inducible Prx1 model 
has since become available and we determined that expression directed by this promoter is 
highly restricted to the cambium layers in the periosteum and perichondrium after birth. To 
determine the postnatal role of these cambium layer osteochondroprogenitors (CLOPs) and their 
primary cilia, we developed models to track the fate of CLOPs (Prx1CreER-GFP; Rosa26tdTomato) 
and selectively disrupt their cilia (Prx1CreER-GFP; Ift88fl/fl). Our tracking studies revealed that 
CLOPs populate cortical and trabecular bone, the growth plate, and secondary ossification 
centers during the normal program of postnatal skeletogenesis. Furthermore, animals that lack 
CLOP cilia exhibit stunted limb lengthening and thickening due to disruptions in endochondral 
and intramembranous ossification, respectively. Histological examination indicates ossification 
is stunted due to limited differentiation, proliferation, and/ or abnormal hypertrophic 
differentiation in the growth plate. Collectively, our results suggest that CLOPs are programmed 
to rapidly produce bone tissue in vivo in a primary cilium-mediated mechanism.      
Introduction 
 Embryonic and juvenile skeletal development occurs via intramembranous and 
endochondral ossification to provide an important foundation for adult bone health. Embryos 
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undergo mesenchymal condensation to produce cartilaginous structures surrounded by a thin 
layer of fibrous tissue, known as the perichondrium. These skeletal templates eventually become 
mineralized bone via intramembranous and endochondral ossification. In the appendicular 
skeleton, the surrounding perichondrium provides precursors that form the bone collar, a cuff of 
spongy bone around the cartilaginous diaphysis, which supports and preserves the proper shape 
as the limbs develop. Blood vessels penetrate the bone collar, enabling perichondrial progenitors 
to form a primary ossification center in the diaphysis. After birth, secondary ossification centers 
appear in the epiphyses such that cartilaginous sections separate the secondary and primary 
ossification centers. These areas are known as the epiphyseal plates, or growth plates, and are 
responsible for postnatal lengthening of the limbs. The periosteum surrounds the diaphysis as it 
is converted into bone and provides osteoblasts that deposit appositional layers of bone via 
intramembranous ossification to thicken the postnatal skeleton.  
The periosteum and perichondrium contain progenitors capable of differentiating into 
various cell types that populate skeletal tissues. A portion of cells in the inner cambium layers of 
the periosteum and perichondrium express Prx1, a homeobox protein whose expression is highly 
restricted in the postnatal skeleton53. These Prx1-expressing cells are deemed osteochondro-
progenitors (OCPs) because they preferentially commit to a chondrogenic and/ or osteogenic 
fate53,54. Cells in the periosteum have long been known to possess osteogenic characteristics in 
vitro53,84,108–110 and form cartilage and bone in vivo49,95,111–113, but only recently have Prx1-
expressing cells in the cambium layer been proposed as the periosteum’s main source of 
OCPs114.  
Prx1-expressing cells are critical for embryonic skeletal development and survival, but 
have not yet been studied in the context of postnatal development. Prx1 is expressed throughout 
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the embryonic limb bud mesenchyme and a subset of the craniofacial mesenchyme as early as 
9.5 days post coitum. By 10.5 dpc, essentially all of the mesenchymal cells in the limb express 
Prx115 115. Not surprisingly, these Prx1-expressing cells contribute to formation of the growth 
plate, the bone collar, and secondary ossification centers and, subsequently, impact endochondral 
ossification47,116. In fact, this cell population is so critical that Prx1 mutants do not survive 
birth47,54,117. Prx1-expressing cells have not been studied during postnatal development, when 
skeletal growth is most rapid118–120, partially due to the embryonic lethality associated with 
current models. Recently, Kawanami et al. developed an inducible model and found that Prx1 
expression is more restricted in the limbs after birth53. This group suggests Prx1 expression is 
primarily in the periosteum and perichondrium, but the full postnatal expression profile is 
incomplete.  
Periosteal progenitors populate adult skeletal tissues in response to mechanical 
stimulation or fracture. Progenitor cells generally demonstrate upregulation in osteogenic 
markers when subjected to physical stimuli in vitro39,40,88, so it is perhaps not surprising that 
cambium-derived cells generate bone in response to mechanical cues in vivo33,95–97. Fracture 
studies suggest periosteal progenitors significantly contribute to callus formation114, and a 
considerable portion of these cells are derived from a Prx1-expressing population53,54. 
Interestingly, Colnot et al. determined that bone marrow and periosteum both supply osteoblasts 
to facilitate skeletal repair, but only the periosteum provides chondrocytes. Compared to marrow, 
the periosteum is therefore the primary contributor to post-fracture repair, which is dominated by 
endochondral ossification95. Collectively, these studies suggest the adult periosteum contains a 




A mechanism by which osteochondroprogenitors may mediate differentiation is through 
their primary cilia, solitary sensory organelles that project from the cell membrane and are found 
in almost every mammalian cell. The cilium is an established mechanosensor and is known to be 
instrumental in progenitor osteochondrogenesis39,121. The primary cilium is also a potent 
chemosensor that directs left-right patterning and functions as a nexus for signaling pathways 
during embryonic vertebrate development122,123. Haycraft et al. disrupted primary cilia in Prx1-
expressing cells and observed severe defects in embryonic development of the appendicular 
skeleton, including dwarfism, polydactyly, an inability to form the bone collar or secondary 
ossification centers, and abnormal growth plate structure. This knockout was so severe that 
mutants did not survive birth due to malformed ribcages98 and, consequently, the role of Prx1-
expressing cell primary cilia is yet to be examined after birth. However, it is likely that these 
cells and their cilia are also critical for postnatal development, given the extent to which they 
contribute to embryonic skeletogenesis and adult bone formation. 
Progenitors in the cambium layers and their cilia are promising candidates for 
intramembranous and endochondral ossification, but are surprisingly understudied. The postnatal 
appendicular skeleton thickens via intramembranous ossification, whereby osteoblasts are 
directly recruited from the periosteum to lay down appositional layers of new bone. Additionally, 
in endochondral ossification, chondrocytes of undetermined origin populate the growth plate, 
proliferate, and undergo hypertrophy to lengthen the limbs. Yang et al. proposed a model 
whereby periosteal and perichondrial progenitors differentiate into growth plate chondrocytes, 
some of which further differentiate into osteoblasts, but studies have yet to confirm whether 
these progenitors are indeed a source of chondrocyte and osteoblast progeny124. Furthermore, 
there are no current studies on periosteal or perichondrial primary cilia in postnatal development. 
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Rosa Serra’s group has extensively studied the role of chondrocyte cilia in the growth plate and 
found that deletion of a key ciliary gene, Ift88, results in decreased proliferation and accelerated 
chondrocyte hypertrophy, due to disruption of many cilium-mediated signaling pathways82,125. 
They also determined cilia orientation is critical to chondrocyte proliferation, consistent with 
work from other groups that suggest a function for cilia polarity47,126–129. In an in vivo 
overloading model, Rais et al. determined that chondrocyte cilia sense mechanical loading of the 
growth plate and accelerate chondrocyte hypertrophy in response to increased loads130. In fact, 
chondrogenesis is highly dependent on chondrocyte mechanosensing, which is mediated through 
the cilium121,131. Overall, it is possible that Prx1-expressing cells reside in the cambium layers 
and contribute to postnatal ossification through a cilium-dependent mechanism, but this is yet to 
be confirmed due to the lack of an in vivo model. 
Due to the osteochondrogenic nature of Prx1-expressing cells and extent to which 
chondrocyte cilia regulate endochondral ossification, we seek to determine the role of cambium-
derived progenitors in postnatal skeletogenesis as mediated by their primary cilia in vivo. We 
developed a model that allows us to disrupt primary cilia to test our hypothesis that cambium-
layer OCPs require cilia to participate in postnatal skeletogenesis. Additionally, we developed a 
mouse model to track Prx1-expressing cells as they differentiate and become incorporated in new 
juvenile skeletal tissues in vivo. We anticipate that the knowledge gained from studying postnatal 
development will provide insights on how to recapitulate skeletogenesis in vivo and more 




Materials and Methods 
Animal models 
All mouse models are on a C57BL6 background. Prx1CreER-GFP mice were bred with 
Kif3afl/fl, Ift88fl/fl, or Rosa26tdTomato mice to generate Prx1CreER-GFP; Kif3afl/fl, Prx1CreER-
GFP; Ift88fl/fl, and Prx1CreER-GFP; Rosa26tdTomato offspring, respectively. Kif3afl/fl and Ift88fl/fl 
females were bred with Prx1CreER-GFP; Kif3afl/fl and Prx1CreER-GFP; Ift88fl/fl males to 
generate Prx1CreER-GFP; Kif3afl/fl and Prx1CreER-GFP; Ift88fl/fl experimental pups and 
Kif3afl/fl and Ift88fl/fl littermate controls that received tamoxifen injections (Figure 3.1). To avoid 
embryonic recombination, mothers were isolated for one month after any potential exposure to 
tamoxifen before breeding again. We also intentionally selected controls so all mice receive 
tamoxifen since there are reports of cross contamination between animals housed together or that 
use the same experimental equipment. Genotype was determined using PCR and agarose gel 
electrophoresis. Animals were housed, maintained, and evaluated for health complications in 
accordance with IACUC standards. The Institute of Comparative Medicine at Columbia 
University approved all experiments. 
Tamoxifen injections 
Tamoxifen (Sigma Aldrich, T5648) was dissolved in corn oil (Sigma Aldrich, C8267) in 
a shaking incubator at 37°C to create a 20 mg/mL stock solution stored at 4°C and protected 
from light. Injection solution was prepared fresh daily by diluting the stock solution to 10 mg/mL 
and adding 10% ethanol to prevent infection. Prx1CreER-GFP; Kif3afl/fl and Prx1CreER-GFP; 
Ift88fl/fl experimental pups and Kif3afl/fl and Ift88fl/fl littermate controls received daily 
intraperitoneal injections of 33 mg/kg tamoxifen solution until sacrifice. Prx1CreER-GFP; 
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Rosa26tdTomato pups either received a single dose of 100 mg/kg or daily injections of 33 mg/kg 
tamoxifen solution until sacrifice. Pups were injected as early as postnatal day 7 (P7) depending 
on the group to which they were randomly assigned (Figure 3.1). Prx1CreER-GFP; Kif3afl/fl and 
Kif3afl/fl pups were injected daily with 33 mg/kg tamoxifen solution from P7 – P30 since they 
were solely used to initially assess the safety of our injection protocol. The injection site was 
swabbed with 70% ethanol and animals were weighed with an electronic scale immediately prior 
















Figure 3.1: Experimental groups selected to evaluate juvenile skeletal development 
Following normal embryonic development, postnatal transgenic mice received injections of tamoxifen to induce Cre 
recombination-mediated tdTomato expression or primary cilia deletion exclusively in CLOPs. The earliest injections 
were administered at postnatal day 7 (P7) in order to allow secondary ossification centers (SOCs) in the ulnae to 
develop normally132. SOCs in the ulnae generally unite by P17 and our preliminary injection trials suggested P30 
was optimal to observe significant increases in limb length and growth plate (GP) senescence. The group injected at 
P7 and sacrificed (red X) at P17 serves to evaluate the role of CLOPs and their cilia in SOC unification, while the 
P17 – P30 group functions to determine their behavior if SOCs are already united. The P7 – P30 group was selected 
to observe the overall contribution of CLOPs and their cilia to juvenile skeletal development. Animals received a 
single or daily injections until sacrifice depending on the experiment. 
 
Histology 
Upon sacrifice, ulnae were dissected and fixed overnight at 4°C. Prx1CreER-GFP; 
Ift88fl/fl and control specimens were fixed in 10% formalin (Sigma Aldrich, HT5011), 
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decalcified, embedded in paraffin, and sectioned in 5 µm increments. Prx1CreER-GFP; 
Rosa26tdTomato ulnae were fixed in 4% paraformaldehyde (Sigma Aldrich, P6148), decalcified, 
and cryosectioned in 5 µm increments. Prior to decalcification, the midpoint along the length of 
each ulna was measured and marked with tissue stain to ensure transverse sections were 
collected at the same region.  
Staining and immunohistochemistry  
Cryosections were placed in distilled water upon removal from the freezer, incubated in 
mounting media containing a nuclear stain (Electron Microscopy Sciences) for 5 minutes, 
washed with PBS, mounted, and sealed. Paraffin embedded specimens were deparaffinized and 
rehydrated in a tissue processor (Leica ASP300S). Toluidine solution was prepared by diluting 
0.05% w/v Toluidine Blue-O (Sigma Aldrich, T3260) in 100 mM sodium acetate buffer, pH 6. 
Slides were submerged in Hematoxylin solution (Sigma Aldrich, MHS1) for 10 minutes 
followed by 30 seconds in Eosin solution (Sigma Aldrich, HT110216), or submerged in 
Toluidine solution for 10 minutes. To identify proliferating cells in the growth plate, slides were 
incubated in 2 mg/mL hyaluronidase (Sigma Aldrich, H3884) for 1 hour at 37°C, blocked with 
15% goat serum (abcam, ab7481) for 20 minutes at room temperature, and incubated in a PCNA 
primary (abcam, ab29) 1:10,000 in 15% goat serum for 1 hour at 37°C, followed by overnight 
incubation at 4°C. To detect hypertrophic cells in the growth plate, slides were incubated in 2 
mg/mL hyaluronidase for 1 hour at 37°C, blocked with 15% goat serum and 0.3% Triton-X 100 
(Sigma Aldrich, T9284) in PBS, and incubated in a Type X Collagen primary antibody (abcam, 
ab58632) 1:250 in 3% goat serum and 0.3% Triton-X 100 overnight at 4°C. Both PCNA and 
Type X slides were incubated in a fluorescent secondary antibody, Alexa Fluor 488 (Life 
Technologies, A11029 and ab150077) 1:500 in PBS, for 1 hour at room temperature. All slides 
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were washed with PBS then distilled water, mounted, and sealed. Toluidine and H&E stains 
were visualized on an Olympus CKX41 inverted microscope and micrographs were captured 
with a Canon EOS60D 18.0 MP digital SLR camera. All fluorescent images were collected using 
an Olympus Fluoview FV1000 confocal microscope and software.   
Quantifying length, area, and cell count 
Ulnar length and area were quantified from H&E images using Image J software. 
Proliferating cells were counted and normalized to growth plate area from PCNA IHC slides 
using Image J. At least four consecutive sections per specimen were analyzed and averaged 
when assessing differences in phenotype and quantifying ulnar length, cortical or marrow area, 
and number of proliferating cells. Investigators were blinded to the groups during the 
experiment, specimen generation, image acquisition, and post-imaging analysis steps. 
Quantifications were performed by two separate investigators to assess repeatability and ensure 
accuracy of reported results.   
Statistics 
No sex-dependent differences were identified according to a 2-way ANOVA so males 
and females were grouped together for all experiments. All data were analyzed with a two-tailed 
student’s t-test and values are reported as mean ±SEM, with p < 0.05 considered statistically 
significant. Sample size was determined in order to achieve a power of at least 80%.    
 
Results  
Successful generation of mouse models 
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 PCR and gel electrophoresis confirmed that we generated Prx1CreER-GFP; Ift88fl/fl and 
Ift88fl/fl littermates, as well as Prx1CreER-GFP; Rosa26tdTomato reporter mice (Figure 3.2). We 
utilized the same procedure to confirm genotypes in our previously established Prx1CreER-GFP; 
Kif3afl/fl and Kif3afl/fl colonies (data not shown). 
 
 
Figure 3.2: Prx1-driven cilia knockout and fluorescent reporter models were generated 
Gel electrophoresis confirmed Prx1CreER-GFP animals were successfully crossed with (a) Ift88fl/fl mice to generate 
a conditional cilium knockout (Prx1CreER-GFP; Ift88fl/fl) and (b) Rosa26tdTomato animals to produce a Prx1CreER-
GFP; Rosa26tdTomato fluorescent reporter model.  
 
 
Creation of tamoxifen injection protocol 
Since there are no published reports of long-term tamoxifen injections in young pups, we 
sought to determine a safe, yet effective dosing regimen to induce genetic recombination without 
compromising animal health. Due to off-target effects of Kif3a, deletion of Ift88 has since been 
shown to be a more appropriate tool for specifically disrupting the primary cilium68. During the 
process of generating Prx1CreER-GFP; Ift88fl/fl animals, we tested our injection protocol on our 
available Prx1CreER-GFP; Kif3afl/fl stock. We administered 33 mg/kg tamoxifen via 
intraperitoneal injection each day from P7 – P30 based on a published week-long regimen in P0 
– P10 pups133. At P30, Prx1CreER-GFP; Kif3afl/fl experimental animals did not exhibit 
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noticeable changes in ambulation, diet, weight, or cage activity compared to Kif3afl/fl controls as 
a result of the injections. Injected animals consistently weighed less than non-injected controls 
from P10 – P15, but all animals were a similar weight by P20. One study reports that a single 
injection of tamoxifen killed over 90% of gastric cells in normal mice 3 days after 
administration, but gastric histology eventually returned to normal134. This timeline is similar to 
the phenomena we observed and explains the temporary weight loss. This protocol produced 
identical results in our Prx1CreER-GFP; Ift88fl/fl animals.  
Prx1 expression is restricted to the cambium layers in the appendicular skeleton after birth 
The vast majority of limb bud mesenchymal cells express Prx1 during embryonic 
development; however, recent studies indicate Prx1 expression is highly restricted to the calvaria 
and specific regions of the appendicular skeleton after birth53,54. In order to fully characterize 
postnatal Prx1 expression in the forelimbs at our chosen experimental time points (Figure 3.1), 
we injected Prx1CreER-GFP; Rosa26tdTomato pups with a single dose of 100 mg/kg tamoxifen at 
P7, P17, or P28. Pups were sacrificed two days following injection and we visualized GFP to 
identify cells that currently express Prx1, as well as tdTomato—which denotes CreER 
recombination—to track cells that expressed Prx1 at the time of injection. At every time point, 
Prx1 expression was observed in the cambium layers of the perichondrium (Figure 3.3a) and 
periosteum (Figure 3.3b). In mice injected at P7, Prx1-expressing cells were found in the ulnar 
growth plate near the Groove of Ranvier, where progenitors are believed to be rapidly recruited 
to supply chondrocytes to the growth plate135. Very few Prx1-expressing cells were identified in 
the Groove of Ranvier in mice injected at P17 and P30 juvenile growth plates had none. In the 
four P30 specimens, a total of three osteocytes located near the periosteal edge expressed Prx1. 
All Prx1-expressing cells found in the growth plate and cortical bone also expressed tdTomato 
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(Figure 3.3a), indicating Cre recombination had occurred. At every time point examined, cells 
that solely expressed tdTomato were found in the periosteum, perichondrium, cortical bone, and 
both the resting zone and Groove of Ranvier in the growth plate. Cre recombination was absent 
from all other tissues, other than a negligible number of cells in the epiphyseal growth plate in 
one P7 specimen. 
Overall, Prx1 expression was highly restricted to the cambium layers of the periosteum 
and perichondrium, had a trivial presence in the growth plate and cortical bone, and was 
completely absent from epiphyseal centers, trabecular bone, marrow, muscle, connective tissue, 
and cartilage in the juvenile forelimbs. For this reason, we refer to the cell population examined 
in this study as Cambium Layer OsteochondroProgenitors, or CLOPs. 
 
 
Figure 3.3: Prx1 expression is highly restricted to the cambium layers of the periosteum 
and perichondrium in the forelimbs after birth 
Cells currently expressing Prx1 (green), cells that expressed Prx1 at the time of injection two days prior (red), and 
nuclei (blue) in a Prx1CreER-GFP; Rosa26tdTomato reporter model. Cells expressing Prx1 at P7 (closed arrows) were 
identified in the perichondrium (PC), periosteum (PO), Groove of Ranvier (GR) in the growth plate (GP), and 
cortical bone (CB) at P9 (a). All Prx1-expressing cells located outside the cambium layers also expressed tdTomato 
(a, asterisks). Cells that underwent Cre recombination (open arrows) were observed in the perichondrium and 
growth plate. At P30, Prx1-expressing cells were found in the periosteum, which also contained more recombined 
cells than the earlier time points (b). Soft tissues, such as muscle (M), and bone marrow exhibited autofluorescence 
but lacked tdTomato-expressing cells or GFP signal that would indicate Prx1 expression. Injection period (white) 




Progenitors initially in the cambium layers populate a number of juvenile skeletal tissues 
We then utilized our reporter model to histologically track the fate of CLOPs as they 
differentiate and populate tissues outside the cambium layers. Prx1CreER-GFP; Rosa26tdTomato 
mice received a single tamoxifen injection at either P7 or P17 to activate tdTomato expression in 
CLOPs and their progeny until sacrifice at P17 or P30. CLOPs residing in the cambium layers at 
P7 were found in the growth plate, proximal ulnar head, styloid processes, trabecular and cortical 
bone, and the endocortical surface at P17 and P30 (Figure 3.4). CLOPs initially in the cambium 
layers at P17 populated the same areas at P30 but were fewer in number compared to those 
tracked at P7. P7 activated cells were absent from the cambium layers by P17 (Figure 3.4c), but 
P17 activated cells were still present in the periosteum and perichondrium at P30 (Figure 3.4d). 
In the growth plate, both P7 and P17 activated cells were primarily found in the resting zone or 
trabecular bone beneath the growth plate, suggesting CLOPs rapidly proliferate and undergo 
hypertrophy to form ossified bone. We then injected Prx1CreER-GFP; Rosa26tdTomato mice daily 
to determine the overall CLOP contribution to skeletal development from P7 – P30 (Figure 3.4e). 
Indeed, CLOPs make up a significant portion of cells in the aforementioned regions. In fact, the 
majority of osteocytes and osteoblasts in cortical and trabecular bone, respectively, originated 
from the cambium layers, and the styloid and coronoid processes were almost entirely composed 
of CLOPs. In the growth plate, CLOPs were found in the proliferation and hypertrophic zones in 
addition to the resting zone, indicating these progenitor cells participate in the normal program of 
endochondral ossification. Overall, the CLOP presence in ossified and cartilaginous tissues 
further confirms their osteochondrogenic nature53,54, and the extent to which their progeny 




Mice lacking CLOP primary cilia have stunted intramembranous ossification  
The primary cilium is critical to osteogenic differentiation of progenitors39,40 so we 
investigated the role of CLOP cilia in juvenile skeletogenesis. Progenitors in the inner cambium 
layer of the periosteum are known to differentiate into bone-forming osteoblasts that deposit 




























Figure 3.4: CLOPs initially in the cambium layers populate cartilage and bone tissue 
throughout the limb 
At P30, CLOPs initially residing in the periosteum and perichondrium at P7 and their progeny (red) were found in 
the epiphyseal disk (ED) and coronoid process (CP) in the proximal head of the ulna (a) and cortical bone (CB), but 
absent from bone marrow (BM), and muscle (M) (b). These progenitors were also observed in the ulnar growth plate 
(GP), styloid process (SP), and trabecular bone (TB). At P17, these progenitors were found in the GP, SP, and TB, 
but absent from the periosteum (PO) and perichondrium (PC) (c). CLOPs initially in the cambium layers at P17 
populated the PO, PC, GP, SP, and TB (d). CLOPs in the cambium layers from P7 until sacrifice at P30 and their 
progeny were found in the GP, SP, TB, PO, and PC (e). Nuclei are displayed in blue. Injection period (white) and 
day of sacrifice (red) are noted in the upper right corner of each image. White scale bars represent 100 µm.  
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 cilia mediate this mechanism of intramembranous ossification, Prx1CreER-GFP; Ift88fl/fl pups 
were injected daily with tamoxifen to eliminate production of a protein critical to cilia formation 
and maintenance (IFT88) in order to disrupt CLOP primary cilia. We quantified cortical area and 
found that mutants developed significantly less cortical bone than their respective controls in all 
of the injection groups (Figure 3.5a). Surprisingly, knockouts initiated at P7 also had wider 
marrow canals (Figure 3.5b). This effect was not seen in knockouts initiated at P17, suggesting 
that progenitor disruption has a greater impact in the earlier stages of juvenile skeletogenesis. 
 
 
Figure 3.5: Mice lacking CLOP primary cilia exhibit stunted limb development and growth 
plate chondrocyte proliferation 
Juvenile transgenic mice lacking primary cilia (Prx1CreER-GFP; Ift88fl/fl) developed less cortical bone compared to 
controls (Ift88fl/fl) at all developmental stages examined (a). Additionally, the cortical marrow lumen area was 
greater in knockouts initiated at P7 (b). This phenotype was absent in the P17 – P30 mutants, which had similar 
areas compared to controls. Mutants also had attenuated limb lengthening (c) and significantly fewer proliferating 




































Figure 3.6: Juveniles lacking CLOP cilia demonstrate abnormal growth plate morphology 
H&E stains were performed to discern ulnar growth plate zones (black dashed lines). The proliferating zones in P7 – 
P17 mutants contained noticeable cartilaginous sections lacking cells (b, red dashed box). These non-cellularized 
regions were not present in controls (a), which were densely populated with cells. Chondrocytes in the P17 – P30 
control proliferation zones were neatly arranged in vertical columns (c, solid blue box); however, this structure was 
much less organized or completely absent in mutants (d, blue dashed box). The lack of columnar organization and 
flatter morphology normally associated with proliferating cells also made it difficult to distinguish the resting and 
proliferation zones in P17 – P30 mutants (d). Ossified bone normally present in the styloid processes above the 
growth plate (c, e) was lacking in P17 – P30 (d) and P7 – P30 (f) mutant growth plates. Although the growth plate 
zones were distinguishable in the P7 – P30 group, mutants appeared to have larger hypertrophic zones compared to 
controls (e, f). Black scale bars represent 50 µm.  
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Endochondral ossification is attenuated in mutants 
Embryos lacking primary cilia in Prx1-expressing cells have severely shortened limbs47 
so we also examined ulnar length in juveniles with and without CLOP cilia. At each time point, 
mutants had significantly shorter ulnae compared to their respective controls (Figure 3.5c). In 
fact, mutants assessed at P30 had shorter ulnae than P17 controls. Mutants disrupted beginning at 
P7 had shorter average lengths at P30 compared to those injected at P17.  
Because limb lengthening occurs via endochondral ossification, which depends on proper 
growth plate chondrocyte differentiation and proliferation, we investigated differences in growth 
plate morphology. At all stages, mutants demonstrated abnormal phenotypes but the 
characteristics and severity varied. Growth plate zones (Figure 3.6, black dashed lines) can be 
roughly determined by observing cell morphology. Chondrocytes in the resting zone are round 
with spherical nuclei but eventually flatten and align in vertical columns to rapidly proliferate, 
until they finally expand into cuboidal hypertrophic cells. P7 – P17 knockouts contained 
noticeable patches in the proliferation zone that lacked chondrocytes (Figure 3.6b, red dashed 
box), suggesting fewer cells populated the growth plate (Figure 3.6b). The boundary between the 
resting and proliferation zones was less distinct in P7 – P17 and P17 – P30 mutants. Columnar 
stacking was prevalent in P17 – P30 controls (Figure 3.6c, blue solid box); however, this 
behavior was almost entirely lost in mutants (Figure 3.6bd, blue dashed box). The hypertrophic 
zone in P7 – P30 mutants appeared to be much larger than controls (Figure 3.6e,f). Finally, 
controls evaluated at P30 exhibited ossification in the styloid processes (Figure 3.6c,e), which is 
correlated with growth plate senescence; however, this phenomenon was drastically less 
pronounced in mutants (Figure 3.6d,f). Overall, the phenotypic variation with timing of 
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disruption suggests the predominant role of CLOP primary cilia, or CLOPs themselves, may 
change with each successive stage of juvenile development. 
 
 
Figure 3.7: Mice lacking CLOP cilia exhibit ectopic hypertrophy in the growth plate  
Type X Collagen stains were performed to identify growth plate chondrocytes undergoing hypertrophy (green). In 
all control groups (a, c, e), hypertrophic cells were found exclusively at the proximal end of the growth plate, where 
the hypertrophic zone is normally present (white dashed lines). Mutants examined at P17 had smaller hypertrophic 
zones compared to controls and contained hypertrophic cells in the resting/ proliferation zones (b, white box). 
Mutants examined at P30 also contained hypertrophic cells in the resting/ proliferation zones (d, f, white boxes). 




In order to evaluate these observed differences in growth plate morphology, we 
performed immunohistochemistry for markers of growth plate chondrocyte proliferation (PCNA) 
and hypertrophy (Type X Collagen). Indeed, mutants had fewer cells in the proliferation zone 
compared to controls (Figure 3.5d) regardless of when progenitor primary cilia were disrupted. 
P7 – P17 mutants generally had smaller hypertrophic zones (Figure 3.7a,b) that were easily 
distinguishable from corresponding proliferation zones. In contrast, the P17 – P30 (Figure 3.7d) 
and P7 – P30 (Figure 3.7f) mutants did not have distinct hypertrophic and proliferation zones. 
Ectopic hypertrophy was present near the border between resting and proliferation zones in all 
mutant groups (Figure 3.7b,d,f); however, these chondrocytes were primarily found near the 
Groove of Ranvier in P7 – P17 mutants, but present throughout the entire growth plate in groups 
evaluated at P30.  
Secondary ossification centers are underdeveloped in mutant juveniles 
Prx1-expressing cells are known to form ossification centers during embryonic 
development47,136, and our tracking studies reveal CLOPs continue to populate ossification 
centers in juvenile skeletogenesis (Figure 3.4). We therefore performed Toluidine Blue-O stains 
to examine ossification in the epiphyses and trabecular bone proximal to the ulnar growth plate. 
At P30, mice lacking primary cilia (Figure 3.8b,d) had less bone and vasculature in the proximal 
head compared to controls (Figure 3.8a,c). Mutant epiphyseal disks stained a lighter purple than 
their respective controls, suggesting they have lower proteoglycan contents. Furthermore, mutant 
epiphyseal disk cartilage also contained ectopic hypertrophic chondrocytes similar to those 
examined in the distal ulnar growth plates (Figure 3.7). These phenotypic differences were 
slightly more severe when the knockout was initiated at P7 (Figure 3.8b) compared to P17 
(Figure 3.8d). In the trabecular space, controls examined at P30 (Figure 3.8e) had fewer cartilage 
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nodules and more bone with increasing distance from the growth plate. Although mutants 
exhibited a similar pattern proximal to the growth plate, they contained more retained cartilage 
and less bone compared to controls (Figure 3.8f). The phenotypic differences in the trabecular 
space were equally severe whether the knockout was initiated at P7 or P17. Interestingly, 
ossification in the aforementioned regions was comparable between mutants and controls in the 
P7 – P17 group. 
 
Figure 3.8: General ossification is stunted in juveniles when CLOP cilia are deleted 
Toluidine Blue-O stains were performed to identify cartilage (purple), mineralized bone (off-white), and marrow 
(light blue) in the limbs of mice with and without CLOP primary cilia. The epiphyseal disk in P7 – P30 mutants (b) 
contained more cartilage and less bone than controls (a). This phenotype was also present in P17 – P30 controls (c) 
and mutants (d) but not as pronounced. All mutants (f) examined at P30 had a greater presence of cartilage nodules 
and mineralized cartilage in the trabecular space proximal to the growth plate, while controls (e) contained more 





Despite its ubiquity in the embryonic limb bud, Prx1 expression is highly restricted to the 
cambium layers after birth. When the Prx1CreER-GFP model was first developed, Kawanami et 
al. injected a Rosa26lacZ reporter at postnatal day 19 (P19) and assessed Cre recombination at 
P23 to report the presence of Prx1-expressing cells53. However, observing Cre activity 96 hours 
later may not accurately represent Prx1 expression at the time recombination was triggered since 
skeletal development occurs rapidly in mice, especially in the first 3 weeks after birth118–120. In 
fact, it takes only 48 hours for chondrocytes to transition through the hypertrophic zone and 
become bone-forming osteoblasts in the primary spongiosa124. Another study of the murine 
forelimb suggests the entire hypertrophic zone turns over once every 24 hours132. For this reason, 
it is perhaps more appropriate to evaluate the presence of GFP, which is dependent on Prx1 
expression, instead of Cre recombination. Furthermore, their group did not fully characterize 
Prx1 expression in the early days after birth, when important developmental milestones occur 
that are of interest when studying postnatal skeletogenesis. 
We therefore crossed the Prx1CreER-GFP model with a Rosa26tdTomato reporter and 
visualized GFP to detect Prx1 expression in the forelimb, as well as tdTomato to evaluate Cre 
activity 48 hours after recombination was induced. Kawanami et al. identified the vast majority 
of recombined cells in the cambium layers, with some in tendon, the epiphyses, and articular 
cartilage, and very few at the endocortical surface and in bone marrow53. In agreement with 
Kawanami et al., we found Prx1-expressing cells were primarily in the cambium layers of the 
periosteum and perichondrium and to a lesser degree in tendon. Since postnatal development is 
so rapid, the Prx1-expressing chondrocytes we found in the growth plates of P7 activated mice 
are likely recently differentiated progenitors recruited via the Groove of Ranvier135. Indeed, 
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Kawanami et al. no longer detected recombined cells in epiphyseal chondrocytes at P26, merely 
96 hours after they observed them in P23 mice53. Additionally, because it takes 26 hours for GFP 
to turn over137, these cells may not express Prx1 but still contain residual GFP protein. Using our 
red fluorescent reporter to trace cells with activated Cre, we found recombined cells in the same 
locations Kawanami identified, but did not detect accompanying Prx1 expression in the marrow 
space, articular cartilage, epiphyses, or endosteum. This indicates postnatal Prx1 expression is 
much more restricted to the cambium layers than previously believed and that these progenitors 
possess a surprising ability to rapidly populate skeletal tissues. We therefore conclude that this 
Prx1CreER-GFP model is a valuable tool for studying cambium layer osteochondroprogenitors 
(CLOPs), especially 3 weeks after birth when the most rapid developmental stage has ended.  
Periosteal progenitors have long been thought to participate in intramembranous 
ossification; however, our tracking studies show for the first time that CLOPs are incorporated in 
the postnatal growth plate and engage in endochondral ossification. Prx1-expressing progenitors 
are known to differentiate into cells that contribute to intramembranous and endochondral 
ossification during adult fracture healing53,138, but it is unknown whether these cells operate 
similarly in the normal program of juvenile skeletogenesis. A number of studies indicate 
osteoblasts are recruited from the cambium layer of the periosteum to lay down appositional 
layers of bone via intramembranous ossification139, so perhaps it is not surprising that we found 
differentiated CLOPs embedded in cortical bone near the periosteal surface. Ono and 
Kronenberg determined that cells within the perichondrium and growth plate eventually become 
osteoblasts in the primary spongiosa140. Furthermore, Yang et al. recently discovered that 
hypertrophic chondrocytes become osteoblasts and osteocytes during juvenile development, and 
proposed that progenitors from the periosteum and perichondrium contribute to the osteogenic 
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pool responsible for bone growth124. Our reporter studies provide direct evidence to support this 
hypothesis because we show that progenitors within the cambium layers of the periosteum and 
perichondrium naturally populate the growth plate, cortical bone, trabecular bone, and secondary 
ossification centers. Additionally, our results provide further support that hypertrophic 
chondrocytes can become bone-forming osteoblasts. Hypertrophic chondrocyte fate has been a 
topic of controversy since it was first suggested they do not simply undergo apoptosis141, so it is 
important to highlight any evidence of their osteogenic potential. Finally, our tracking studies 
importantly build on embryonic studies demonstrating that Prx1-expressing cells contribute to 
both forms of ossification98,142. Although Prx1 expression patterns become more restricted with 
age, our results indicate this cell population’s participation in skeletogenesis spans multiple 
stages of development. Moreover, it is now reasonable to suggest CLOPs play a role in adult 
skeletal adaptation, especially since they populate the callus53,95 in response to fracture.   
Primary cilia are known to be critical for embryonic skeletal development, but our results 
suggest their participation in skeletogenesis extends beyond birth. Embryos lacking cilia in Prx1-
expressing cells exhibit severely shortened limbs and loss of bone collar98, a segment of bone 
that forms around the diaphysis to provide structure and support for further endochondral bone 
formation. Although ossification is prevalent in juvenile growth, it was previously unknown 
whether primary cilia in Prx1-expressing cells play a continued role since mutants did not 
survive birth. We generated an inducible knockout to study a postnatal deletion of CLOP 
primary cilia and found that juvenile mutants had disrupted endochondral and intramembranous 
ossification, resulting in shorter and thinner forelimbs. Our immunohistochemistry suggests the 
disruption in endochondral ossification is a combination of attenuated chondrocyte proliferation 
and abnormal hypertrophy in the growth plate. This phenotype is similar to juvenile mice with a 
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conditional chondrocyte cilia knockout82 and suggests for the first time that CLOPs and their 
progeny comprise an appreciable number of the cells present in the growth plate. In their 
embryonic studies, Haycraft et al. determined that Prx1-expressing cells in the perichondrium 
normally differentiate into osteoblasts that form the bone collar, but those lacking cilia tend to 
follow a chondrogenic lineage47. It is therefore likely that Prx1-expressing progenitors in the 
periosteum/ perichondrium lacking cilia are unable to differentiate directly into osteoblasts or 
chondrocytes that eventually become osteoblasts. Overall, our results suggest this cell population 
and their primary cilia are attractive targets for osteoporosis prevention research, since the 
amount of bone accrued during postnatal development is an important factor in determining the 
risk for osteoporosis120 and a variety of skeletal abnormalities are directly tied to the cilium57. 
Although we observed differences in phenotype with each developmental time point, all 
mutants consistently displayed a delayed program of osteogenesis. Juvenile mutants had shorter 
ulnae, fewer proliferating cells in the growth plate, ectopic hypertrophic chondrocytes in 
uncharacteristic zones of the growth plate, and less cortical area regardless of when CLOP 
primary cilia were disrupted. Interestingly, P17 – P30 mutants did not exhibit an increase in 
marrow area like the other groups, suggesting CLOPs influence development of the marrow 
space primarily within the first 2-3 weeks of birth. The marrow space typically widens with age 
as more cortical bone is laid down via intramembranous ossification and osteoclasts 
subsequently resorb bone at the endocortical surface. Our previous work suggests the primary 
cilium mediates formation and resorption to maintain adult bone homeostasis38, so it is possible 
that this disruption also creates an imbalance in juveniles. Although all mutant growth plates 
contained fewer proliferating cells, P7 – P17 mutants suffered from low recruitment of resting 
zone cells, whereas P17 – P30 and P7 – P30 mutants displayed poor columnar stacking and 
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accelerated hypertrophy. Interestingly, the P7 – P30 mutant growth plates regained some 
columnar structure and the boundary between the resting and proliferation zones was more 
distinct compared to the phenotype in P17 – P30 mutants. This recovery implies CLOP cilium 
disruption delays rather than prevents endochondral ossification in juveniles. Indeed, conditions 
that hinder growth plate activity are known to encourage catch-up growth, whereby growth 
occurs more rapidly than normal at a particular age because the growth plate continues to operate 
in the absence of senescence143. Studies suggest growth plate senescence is dictated by the 
progress of growth, rather than age itself143–145, so it is possible that CLOP cilium disruption 
delays senescence and temporarily stunts endochondral ossification. Regardless of whether 
catch-up growth can occur, we did not find evidence that the negative effects of CLOP cilium 
disruption on ossification are recoverable. Lastly, our Toluidine Blue-O stains revealed that P7 – 
P17 mutants did not display the attenuated ossification observed in the other groups. This is 
perhaps expected since secondary ossification centers are not formed until P7 and may not 
undergo detectable changes by P17. 
The phenotypic abnormalities in mutants are potentially due to disruptions in ciliary 
signaling pathways that are known to coordinate intramembranous and endochondral ossification 
(i.e. Ihh, PTHrP, TGFβ, and BMP). Perhaps the most recognized signaling pathway in the 
growth plate is the interplay between Indian hedgehog (Ihh) and parathyroid hormone-related 
protein (PTHrP), which coordinate with the perichondrium to control the timing and rate of 
hypertrophy. The primary cilium has long been known to mediate hedgehog signaling during 
development146, and juvenile mutants lacking chondrocyte primary cilia exhibit disrupted Ihh 
signaling125 and accelerated hypertrophic differentiation82. Although transforming growth factor 
beta (TGFβ) and bone morphogenic protein (BMP) have established roles in skeletal 
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development, only recent studies show that the TGFβ/BMP signaling pathway is directly 
influenced by the primary cilium147,148. Prx1Cre embryos containing a knockout of TGFβ 
receptor 2 exhibit dwarfism and severely attenuated intramembranous ossification149. The 
deficiencies in endochondral ossification are perhaps not surprising since the Ihh/PTHrP 
pathway is believed to work intimately with TGFβ2 and BMP signaling to influence chondrocyte 
hypertrophy150,151. We therefore conclude that our CLOP cilia knockouts display attenuated 
intramembranous ossification in part due to disrupted BMP signaling and exhibit ectopic and 
accelerated hypertrophy as a result of interrupted Ihh, PTHrP, TGFβ, and BMP signaling. 
Chondrocyte proliferation is also limited when primary cilia and their associated 
signaling pathways are disrupted. Chondrocytes in the proliferation zone are able to rapidly 
proliferate by dividing and rotating to stack themselves in tight vertical columns, a process 
known as chondrocyte rotation. Primary cilia are normally oriented along the long axis of the 
growth plate in the proliferation zone and this directionality is critical for rotation to occur82,126–
128. For example, transgenic mice containing a chondrocyte-specific primary cilia knockout 
exhibit randomly oriented cilia in clusters of chondrocytes that fail to vertically align, resulting 
in severely attenuated proliferation82. We also confirmed in our model that the observed 
disorganized clusters in mutant proliferation zones had randomly oriented cilia, if any cilia at all, 
whereas control animals displayed perpendicularly oriented cilia in tight vertical columnar stacks 
(Figure 3.9). It has been suggested that the cilium mediates this process through noncanonical 
Wnt signaling82,125 since chondrocyte rotation is tightly regulated by the planar cell polarity 
(Wnt/PCP) pathway152. In addition to their roles in chondrocyte hypertrophy, Ihh and BMP 
signaling also enhance chondrocyte proliferation. In fact, overexpression of Ihh alone is 
sufficient to enhance proliferation153. Another form of Hedgehog signaling, Sonic hedgehog 
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(Shh), and BMP signaling are believed to trigger resting zone chondrocytes to enter the 
proliferation zone154,155. Collectively, these prior studies suggest our primary cilium knockouts 
cannot adequately recruit cells from the resting zone and those cells that enter the proliferation 
zone fail to engage in chondrocyte rotation due to disruptions in ciliary signaling pathways.  
 
 
Figure 3.9: Orientation of growth plate chondrocyte primary cilia 
In control growth plates (a), proliferating chondrocytes contain cilia (green) that are oriented along the longitudinal 
axis of the limb. In contrast, Prx1CreER-GFP; Ift88fl/fl mutant cilia were randomly oriented and their corresponding 
chondrocytes failed to stack in the tight, vertical columns demonstrated in control growth plates. Nuclei are pictured 
in blue. Micrographs were collected using a confocal microscope (Olympus FV1000) with a 100X oil objective.  
 
In conclusion, our results suggest cambium layer osteochondroprogenitors have greater 
regenerative potential than previously envisioned and are perhaps the most suitable source for 
recapitulating bone regeneration in vivo. Mesenchymal cells are the leading cell type for 
regenerative applications since they self-renew, differentiate into a vast array of cell types, and 
can be extracted from many different tissues33. Bone marrow is a particularly attractive source 
since it contains osteogenic precursors; however, the periosteum has also been identified as a 
clinically useful progenitor source156. Prx1-expressing cells are critical to embryonic 
skeletogenesis98 and the majority of cells in the adult fracture callus are derived from periosteal 
progenitors95. Additionally, periosteum derived progenitors demonstrate high proliferation rates 
in vitro and regenerative performance does not vary with age33. We demonstrated that Prx1-
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expressing cells function as periosteal/perichondrial progenitors in the postnatal skeleton and 
populate a surprising number of nearby and distant skeletal tissues during juvenile development. 
Because of their continued existence after birth, regenerative potential, and pre-programmed fate 
towards an osteogenic lineage, CLOPs are potentially optimal for producing bone tissue in vivo. 
More importantly, we demonstrated that CLOPs differentiate into osteoblasts, hypertrophic 
chondrocytes, and osteocytes, providing a diverse source of progenitors for development, trauma 
response, and adult skeletal homeostasis124. Furthermore, we have shown that disrupting the 
primary cilium alone results in significant skeletal abnormalities, implicating this organelle as a 




Chapter 4: TRPV4 and AC6 mediate calcium/ cAMP dynamics 
during osteocyte primary cilium mechanotransduction 
Abstract 
One mechanism by which osteocytes transduce mechanical stimuli is through the primary 
cilium, which contains a unique microdomain of proteins that facilitate mechanotransduction. 
Our lab recently found that a calcium (Ca2+) channel, TRPV4, and transmembrane proteins that 
produce cAMP, AC3 and AC6, are present in the osteocyte primary cilium. TRPV4 opens via a 
calmodulin (CaM) domain and (Ca2+) binds to AC3 and AC6 to activate and inhibit cAMP 
production, respectively. Osteocyte cAMP levels initially decrease when stimulated, so we 
hypothesize that Ca2+ enters via TRPV4 and inhibits production of cAMP through AC6. The 
objectives of this study are to determine whether 1) Ca2+-mediated opening of TRPV4 is critical 
to osteogenesis and 2) AC6 mediates Ca2+/ cAMP dynamics. AC3/6 overexpression (OE) 
plasmids were generated and their Ca2+ binding pockets were disrupted via site directed 
mutagenesis. Similarly, the calmodulin binding domain was removed from a TRPV4 OE 
plasmid. MLO-Y4 osteocytes were transfected with either the OE, mutant, or vector control 
plasmids via electroporation and either fixed for ICC or exposed to 2 or 30 minutes of oscillatory 
fluid flow (OFF). Protein expression was confirmed via ICC and treatment with forskolin, an AC 
agonist, confirmed the catalytic activity is comparable between OE and mutant plasmids, 
suggesting any detected changes in cAMP production are due to disruption of the binding 
pocket. After 2 min of OFF, cAMP production was drastically increased in AC3 OE and AC6 
Mut OE compared to their respective counterparts. Osteogenesis was attenuated in AC3 OE and  
AC6 Mut OE, suggesting cAMP levels and osteogenesic response are negatively correlated in 
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the early stages of osteocyte mechanotransduction. Furthermore, TRPV4 OE had an enhanced 
osteogenic response compared to controls after 5 and 30 min of OFF, but this effect was lost in  
mutants. These studies demonstrate for the first time that Ca2+ and cAMP are perhaps coupled 
via ACs and influence osteogenesis. Additionally, our results further implicate TRPV4 as the 
mechanism by which Ca2+ enters the cilium during osteocyte mechanotransduction. These 
mechanisms could be targeted to generate therapeutics that promote bone formation to combat 
osteoporosis. We will next use our novel FRET biosensors to characterize Ca2+ influx and cAMP 
production specifically in the cilium with our intact and mutated overexpression plasmids. 
 
Introduction 
 Osteocytes are the mechanosensory cells in bone that control modeling and remodeling of 
the skeleton by signaling to osteoblasts and osteoclasts. Adult skeletal maintenance and 
adaptation is dependent on the osteocyte’s ability to sense physical stimulation and convert these 
signals into intracellular and extracellular processes that encourage bone formation or resorption. 
There are two predominant theories for how osteocytes embedded in cortical bone sense 
mechanical stimulation. First, some researchers suggest osteocytes respond to deformation of the 
bone matrix in the perilacunar space, or fluid-filled pockets in which osteocytes reside. Others 
postulate that fluid flow through the lacunar/canalicular system generates shear stresses that act 
on osteocytes. Our lab primarily explores the effects of fluid shear and the subsequently 
triggered mechanotransduction pathways that lead to osteogenic signaling from osteocytes.   
One mechanism by which osteocytes transduce mechanical stimuli is through the primary 
cilium, which contains a unique microdomain of proteins and signaling molecules that enhance 
mechanotransduction. In response to fluid shear, kidney cilia bend and Ca2+ enters the cilium 
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through a transmembrane protein, polycystin 1 (PC1), interacting with a Ca2+ channel, polycystin 
2 (PC2). Our lab recently found that osteocyte primary cilia experience a similar flow-induced 
Ca2+ influx and this behavior is critical to osteogenesis. However, the osteocyte ciliary Ca2+ 
influx does not occur through the PC1/PC2 complex36. We identified another Ca2+ channel, 
Transient Receptor Potential Vanilloid 4 (TRPV4), is present in the osteocyte cilium and an 
siRNA-mediated knockdown of TRPV4 attenuates flow-induced osteogenesis36. Thus, we 
speculate that, in response to fluid shear, the osteocyte primary cilium bends and Ca2+ enters the 
cilium through the opening of TRPV4 channels. 
Our group has also identified adenylyl cyclases (ACs) in the osteocyte primary cilium 
that are not present in kidney cilia. There are nine transmembrane isoforms of adenylyl cyclase 
but AC3 and AC6 are the only isoforms that also localize to the osteocyte cilium. ACs convert 
ATP to cyclic AMP (cAMP), a signaling molecule that is downregulated in osteocytes at the 
onset of fluid shear35. We previously demonstrated that osteocytes containing siRNA-mediated 
knockdowns of AC6 and Ift88 maintain cytosolic levels of cAMP with fluid shear, resulting in 
attenuated osteogenesis35. Interestingly, the decrease in cAMP production occurs within 2 
minutes but is lost after 30 minutes of applied flow35. This suggests that decreased cAMP levels 
are most important at the onset of flow or another mechanism is at play with increasing exposure 
to physical stimulation. Unpublished work in our lab suggests that an siRNA-mediated 
knockdown of AC3 in osteocytes enhances the osteogenic response to fluid shear after 30 
minutes of applied fluid flow. Thus, we speculate that ciliary AC6 and AC3 play an antagonistic 
role in manipulating cAMP production to trigger osteogenesis. 
TRPV4, AC3, and AC6 all contain Ca2+ binding domains that can be disrupted through 
genetic mutations. Extracellular Ca2+ binds to a calcium-modulated protein (calmodulin, CaM) 
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domain of TRPV4, causing this channel to open and allow Ca2+ to enter the cell76. This CaM 
domain can be removed by eliminating 17 residues beginning at position 814 in TRPV4’s amino 
acid sequence76. The initial studies were performed in proteins in hypotonic solutions, but the 
removal of this TRPV4 CaM domain was later found to inhibit calcium influx in osteoclasts and 
ultimately prevent their activation78. The activity of some AC isoforms, such as AC3 and AC6, 
are modified by binding Ca2+. Protein binding experiments revealed that AC5/6 competitively 
binds Ca2+ and its ability to produce cAMP is inhibited in the bound state157. Another group used 
x-ray crystallography to identify two aspartic acid residues that are critical for AC6 to fold and 
form the binding pocket158. Mutation of these two residues renders AC6 unable to bind calcium 
so it continues to catalyze the conversion of ATP to cAMP. This characteristic is conserved in 
AC5 and AC3; however, AC3 is activated by calcium to produce cAMP80. Therefore, in contrast 
to AC6, disrupting AC3’s binding pocket prevents cAMP production. There is some evidence 
that Ca2+ binding alone does not activate AC3 and occurs after AC3 has already been activated to 
enhance cAMP production, but definitive proof is lacking80.  
We hypothesize that fluid flow in the lacunar/canalicular system bends osteocyte primary 
cilia, allowing calcium to enter through TRPV4 channels and bind to AC6 or AC3. We anticipate 
that in the early initiation of flow, calcium will bind to AC6 and inhibit production of cAMP, 
resulting in an upregulation of osteogenic markers in the osteocyte. The objectives of this study 
are to determine whether 1) Ca2+-mediated opening of TRPV4 is critical to osteogenesis and 2) 




Materials and Methods 
Plasmid Design 
 Entry clones for murine AC6 (MmCD00297230) and human AC3 (HsCD00505998) in 
pENTR223.1 vectors were obtained from the DNASU Plasmid Repository. AC6 and AC3 entry 
clones were inserted into a pcDNA3.2 mammalian expression destination vector (12489019, 
Life) using the Gateway LR Clonase System (Life) to generate pcDNA3.2 + AC6 (AC6 OE) and 
pcDNA3.2 + AC3 (AC3 OE) overexpression plasmids. This kit provides a reaction control entry 
clone, GWCAT, and the resulting pcDNA3.2 + GWCAT overexpression vector (Control OE) 
was used as the empty vector control for all transfection experiments. The pcDNA3.2 vector 
contains a V5 tag at the end of the inserted protein that we used to identify protein expression via 
immunocytochemistry.  
The calcium binding pockets of AC3 and AC6 were disrupted using site directed 
mutagenesis. We identified the two charged aspartic (Asp) acid residues responsible for calcium 
binding and performed point mutations to convert them to neutral alanine (Ala) residues. These 
residues are located in the 324th and 368th positions for AC3 and the 382nd and 426th positions for 
AC6. PCR was performed on the AC3 and AC6 OE plasmids using custom designed mutation 
primers to convert the Asp residues to Ala (Table 4.1). Resulting PCR product was ligated and 
transformed into bacteria using the Q5 Site-Directed Mutagenesis Kit (New England Biolabs), 
which also contained reactants for the PCR. Transformed bacteria were placed onto agar (Sigma) 
plates containing 100 µg/mL Ampicillin for antibiotic selection and incubated at 37°C overnight. 
Individual bacteria colonies were swabbed and grown up in LB broth (Sigma) containing 100 
µg/mL Ampicillin for 16 hours in a shaking incubator (225 rpm) at 37°C. Plasmids were isolated 
from bacteria using a QIAprep Spin Miniprep Kit (Qiagen) and re-suspended in 30 µL nuclease 
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free water (Promega). The resulting plasmids are pcDNA3.2 + AC3Ala 324, 368 (AC3 Mut OE) and 
pcDNA3.2 + AC6Ala 382, 426 (AC6 Mut OE) overexpression plasmids that contain AC3 and AC6, 
respectively, that cannot bind calcium.  
 The TRPV4 OE plasmid was gifted from Dr. Heinrich Brinkmeier at the University of 
Greifswald in Greifswald, Germany. This plasmid contains TRPV4 with a yellow fluorescent 
protein (YFP) tag in a pcDNA3.1 vector. The YFP tag can be used to determine transfection 
efficiency and protein expression in live or fixed cells. The CaM domain was removed using the 
aforementioned site directed mutagenesis protocol with published primer sequences (Table 
4.1)78. The pcDNA3.1 and pcDNA3.2 backbones have negligible differences that will not affect 
this experiment; thus, pcDNA3.2 + GWCAT (Control OE) was also used as a vector control for 
all TRPV4 experiments. 
 All constructed plasmids and sequence mutations were confirmed using Genewiz’s 
Sanger sequencing and custom designed primers (Table 4.1). Control GWCAT OE sequence was 
confirmed using primers provided in the Gateway Clonase kit. Primers were purchased from 
Integrated DNA Technologies and re-suspended in 1 mL nuclease-free water upon arrival 
(Promega), then aliquoted in 10 µM concentrations and stored at -20°C.   
Cell Culture 
 MLO-Y4 osteocyte-like cells were passaged at least twice before used for experiments, 
seeded on Type I Collagen (Corning) coated dishes or glass slides, and cultured in MEMα (Life) 
supplemented with 5% FBS, 5% CS, and 1% PenStrep (Life). Cells were cultured in reduced 
serum media (MEMα supplemented with 2.5% FBS, 2.5% CS, and 0.5% P/S) 48 hours prior to 
fluid flow. MLO-Y4s did not reach over 60% confluence in standard passage, but were grown to 
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reach at least 80% confluence for fluid flow studies. Cells transfected with AC6 OE or AC6 Mut 
OE were cultured in MLO-Y4 media supplemented with 600 ug/mL Geneticin (Life) for 48 
hours the day after electroporation, followed by 48 hours of reduced serum media. AC3 OE and 
AC3 Mut OE specimens received reduced serum media for 48 hours the day after 
electroporation. AC3 and AC6 plasmids were cultured for a total of 3 and 5 days, respectively, 
before experimentation since this is when each plasmid demonstrated peak protein expression. 
Passages 38 – 48 were used for all experiments.  
 
Table 4.2 Mutation and sequencing primers for mutation plasmid design 
 
Transfections 
 For each transfection, 1.25 million MLO-Y4s were re-suspended in 250 µL of BTX 
Buffer (Harvard Apparatus). Plasmid DNA was added to the cells in BTX solution and gently 
flicked to mix, then transferred to a 4 mm gap cuvette for electroporation. The amount of 
plasmid DNA added was normalized to copy number; therefore, AC3 OE/ AC3 Mut OE/ AC6 
OE/ AC6 Mut OE/ TRPV4 OE/ TRPV4 Mut OE specimens received 15 µg and GWCAT 
controls received 7 µg per transfection. Cells were transfected via electroporation using a BTX 
Plasmid Mutation Primers Sequencing Primer 
AC3 Mut OE 
 
324 For: TCCTCTTTGCCGCCATCG 
324 Rev: TGCTGACGTTCTCGTGACG 
368 For: TTAAGATCCTGGGCGCCTGC 




AC6 Mut OE 
 
382 For: TTGAGGGCTTCACCAGCCTG 
382 Rev: TGGCCGCAAACAGGATGCTG 
426 For: TAGGAGCCTGTTACTACTGC 




TRPV4 Mut OE For: CTTCTCCCTGAACAAGAACTCAAGC Rev: TTGTTCAGGGAGAAGCCATAGTACTG For: TCTCTACCACTGACACCCGTTC 
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ECM 360 Electro Cell Manipulator (Harvard Apparatus) to generate a single pulse with settings: 
300 V, 100 Ω, 1000 µF. Cells remained in BTX buffer for no more than 10 minutes to minimize 
cell death. The resulting electroporation solution was split between 4 glass slides for fluid flow 
studies or 4 tissue culture dishes for Forskolin treatment. 10 µL of electroporation solution was 
seeded on 35 mm glass bottom dishes for immunocytochemistry. Cells were rinsed and media 
was changed the morning after a transfection to remove dead cells and facilitate cell recovery. 
Forskolin treatment 
 MLO-Y4s transfected with AC6 OE, AC6 Mut OE, AC3 OE, AC3 Mut OE, and 
GWCAT vector control were split onto 4 tissue culture dishes (100 mm) immediately after the 
electroporation. Transfected cells were cultured to achieve peak protein expression and treated 
with 10 µM Forskolin (Sigma) dissolved in DMSO (Sigma) or vehicle control for 20 minutes at 
37°C. After treatment, cells were rinsed with cold PBS, lysed with 1 mL of 0.1 M HCl (cAMP 
ELISA kit, Enzo) for 10 minutes at room temperature, scraped off the dish, centrifuged at 4°C 
for 15 min at 16 rcf. The resulting supernatant was transferred to a fresh microcentrifuge tube.    
Immunocytochemistry (ICC) 
To determine plasmid expression patterns and cilia incidence/ length, we performed 
double ICC to detect the V5 tag of the destination vector and primary cilia. Cells were fixed with 
4% paraformaldehyde for 10 min at room temperature and blocked with 3% BSA + 2% goat 
serum + 0.1% TritonX-100 (Sigma) in PBS for 1 hour at room temperature. Cells were then 
incubated in primary antibodies against V5 (1:500, Life) and Arl13b (1:1000, Protein Tech), a 
protein localized to cilia, overnight on a rocker at 4°C.  The fluorescent secondary antibodies, 
AlexaFluor 488 (1:500, Life) and AlexaFluor 568 (1:500, Life) were applied for 1 hour at room 
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temperature to detect V5 and Arl13b, respectively. Nuclei were detected using NucBlue 
ReadyProbes (Life). All fluorescent images were collected using an Olympus Fluoview FV1000 
confocal microscope and software.   
Quantifying cilium incidence and length 
Cilium incidence and length were measured by hand from confocal stacks using Image J 
software. At least four images per dish were analyzed to determine the average incidence and 
length per trial. Each transfection was performed on 3 separate occasions to evaluate 
repeatability and consistency between trials. Investigators were blinded to the groups during the 
experiment, staining, image acquisition, and post-imaging analysis steps. Quantifications were 
performed by two investigators to assess repeatability and ensure accuracy of reported results.   
Oscillatory fluid flow (OFF) 
Transfected MLO-Y4s were seeded on glass slides (Fisher Scientific; 75 x 38 x 1 mm). 
Upon reaching 80% confluence, cells were placed in parallel-plate flow chambers 
(56  ×  24  ×  0.28 mm), incubated at 37°C for 30 minutes at rest, and exposed to 2, 5, or 30 minutes 
of OFF at 1 Hz with a peak shear stress of 10 dyn/cm2. For RT-qPCR analysis, samples were 
incubated for an hour (2 and 5 min OFF studies) or 30 min (30 min OFF studies) post-flow and 
were removed from the chambers, rinsed in cold PBS, and lysed immediately with 1 mL 
TriReagent (Sigma Aldrich) to isolate RNA. For cAMP quantification studies, 0.5 mM of the 
phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX) (Sigma) was added to flow 
media to prevent cAMP degradation. At the conclusion of flow, samples were rinsed and lysed 
immediately with 500 µL of 0.1 M HCl (cAMP ELISA kit, Enzo) for 10 minutes. The resulting 
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lysate was centrifuged at 4°C for 15 minutes at 16 rcf and the supernatant was transferred to a 
fresh microcentrifuge tube.  
mRNA quantification 
RT-qPCR was performed to quantify flow-induced changes in Cyclooxygenase-2 (COX-
2) and GAPDH using fluorescent primers (Life Technologies) and an ABI PRISM 7900 
(Applied Biosystems). Samples were performed in triplicate and COX-2 was normalized to 
GAPDH expression levels. OFF samples were normalized to static controls.  
cAMP ELISA 
 Cytosolic cAMP levels were quantified using a kit from Enzo Life Sciences (ADI-900-
163). Samples were analyzed in triplicate and prepared according to the manufacturer’s 
instructions for non-acetylated samples in hydrochloric acid lysis buffer. cAMP levels were 
normalized to total protein content of the lysate, which was determined by a Pierce BCA Protein 
Assay (Thermo Fisher). OFF samples were normalized to static controls. 
Statistics 
Data were analyzed using a one-way ANOVA followed by Bonferroni post-hoc 
correction, or a two-tailed student’s t-test. Values are reported as mean ± SEM, with p < 0.05 
considered statistically significant. Sample size was determined to achieve a power of at least 
80%.    
 
Results 
Protein is overexpressed in transfected MLO-Y4s 
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 We first determined whether our constructed plasmids would result in supranormal levels 
of AC3, AC6, and TRPV4 protein. Double ICC for V5 and AC6 revealed that only 20 – 30% of 
transfected cells overexpressed AC6 3 days post-transfection (PT). We therefore treated these 
cells with Geneticin to select cells that were successfully transfected. With 2 days of Geneticin 
treatment, followed by 2 days of culture in reduced serum media, we achieved 100% efficiency 5 
days PT (Figure 4.1b). We repeated these stains on cells transfected with GWCAT OE, AC3 OE, 
or AC3 Mut OE. For AC3 plasmids, 80-90% of the cells overexpressed AC3 protein 3 days PT. 
Cells transfected with the GWCAT OE plasmid demonstrated > 90% efficiency 3 days PT 
(Figure 4.1) and maintained this behavior 5 days PT. For the TRPV4 plasmids, we visualized 
YFP in live cells and determined that more than 90% of cells overexpressed protein 3 days PT 
(Figure 4.1a). The mutation plasmids exhibited identical expression patterns as their non- 
  
 
Figure 4.1: MLO-Y4s containing our plasmids demonstrate supranormal protein levels  
ICC for V5 (green) revealed that MLO-Y4s transfected with GWCAT (A, bottom), AC3 OE (B, top), and AC6 OE 
(B, bottom) express proteins produced as a result of their respective plasmid. TRPV4 expression was confirmed by 
visualizing YFP (green) (A, top). AC3 and AC6 are pictured in red (B, middle). Nuclei are pictured in blue. Images 
were collected at 20X. This experiment was performed 3 times for each group. 
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mutated plasmids (data not shown). All protein was expressed in the cytosol of MLO-Y4s, which 
is typical for CMV-driven plasmids. For these reasons, AC3/ TRPV4 and AC6 experiments were 
performed 3 or 5 days PT, respectively, and the GWCAT OE plasmid was considered an 
acceptable empty vector control for both of these time points.  
 
AC3 and AC6 catalytic activity is maintained when the calcium binding pocket is disrupted  
AC3 and AC6 modify their catalytic activity by binding Ca2+, but all ACs are activated 
by forskolin. This AC agonist binds at a separate site so ACs are able to produce cAMP 
independent of metal binding. We therefore treated transfected MLOY4s with forskolin to 
confirm that our mutations do not disrupt general AC activity. Indeed, AC3 Mut OE and AC6 
Mut OE specimens had comparable increases in cAMP levels, and therefore similar AC activity 
(Figure 4.2). This result indicates that any changes in cAMP production are a direct consequence 
of disruption of the Ca2+ binding pocket. Furthermore, the activity is elevated compared to 




Figure 4.2: Ca2+ binding pocket disruption 
does not influence general AC catalytic 
activity 
MLO-Y4s were transfected with AC3 (yellow) and AC6 
(green) overexpression plasmids and treated with 
forskolin. Compared to vehicle controls, all specimens 
demonstrated at least an approximate 2-fold increase in 
cAMP production. This increase was comparable between 
OE plasmids and their Mut OE counterparts, as well as 
between AC3 and AC6 specimens. Data are normalized 
to vehicle controls and reported as the mean ± SEM. n = 5 












































Figure 4.3: Increasing TRPV4 and AC6 protein expression enhances ciliogenesis 
Cilia were identified in transfected MLO-Y4s using double ICC for V5 and Arl13b, a protein that localizes to cilia. 
A nuclear dye was used to detect nuclei. 3-D stacks were collected at 100X magnification using a confocal 
microscope. Cilia incidence and length were measured manually using Image J software. Data are presented as mean 
± SEM, **p < 0.001. AC3: Control n = 13, OE n = 15, Mut OE n = 14. AC6: Control n = 15, OE n = 12, Mut OE n 
= 12. TRPV4: Control n = 9, OE n = 8, Mut OE n = 6.  
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Cilium incidence and length increase with overexpression of TRPV4 and AC6, respectively  
Recent work in our lab suggests enhanced ciliogenesis in MLOY4s increases their 
osteogenic response to fluid shear42. We therefore sought to determine whether cilium incidence 
or length increased when these osteocyte ciliary proteins were overexpressed. Interestingly, 
incidence and length increased only with TRPV4 and AC6 overexpression, respectively (Figure 
4.3). AC3 overexpression elicited no change compared to vector controls. This behavior was 
consistent for the mutation plasmids.  
 
Figure 4.4: Flow-induced changes in cAMP levels and COX-2 expression in osteocytes 
overexpressing intact and mutated AC3 
MLO-Y4s were transfected with AC3 OE, AC3 Mut OE, or Control OE plasmids and exposed to 2 or 30 min OFF. 
The AC3 Mut OE group exhibits decreased cAMP levels and enhanced osteogenesis compared to AC3 OE samples. 
Bar graphs represented fold changes with OFF compared to static controls. AC3 OE and AC3 Mut OE data are 




Disrupting the Ca2+binding pocket of AC3 and AC6 alters flow-induced cAMP production 
 
We then sought to determine how cytosolic cAMP levels change when the Ca2+ binding 
pockets of AC3 and AC6 are disrupted. Transfected cells were exposed to 2 min and 30 min of 
fluid shear in order to compare our results to previous work35. Normally, osteocytes exhibit 
decreased levels of cAMP production after 2 min of flow. With 2 min OFF, cells transfected with 
AC3 Mut OE produced less cAMP than those containing AC3 OE (Figure 4.4a), whereas the 
AC6 Mut OE group exhibited increased levels compared to AC6 OE (Figure 4.5a) We have 
previously shown that cAMP levels actually increase after 30 min of flow35. Interestingly, at this 
examined time point, there was no significant difference between AC6 OE and AC6 Mut OE 
samples. The relationship between AC3 OE and AC3 Mut OE persisted with the increase in flow 
duration.   
 
Osteogenesis is attenuated when cAMP production is altered 
We then evaluated changes in flow-induced osteogenesis to identify how cAMP 
production may influence the osteocyte’s response to fluid shear. Specifically, we quantified 
expression of COX-2 under the same conditions as in our cAMP experiments. Osteocytes 
normally demonstrate an increase in COX-2, and therefore increased osteogenesis, with fluid 
shear. Cells transfected with AC3 Mut OE demonstrated enhanced osteogenesis compared to 
AC3 OE at both timepoints examined (Figure 4.4b). AC6 Mut OE had an attenuated osteogenic 
response compared to AC6 OE, but only when flow was applied for 2 min (Figure 4.5b). There 
was no significant difference between AC6 OE and AC6 Mut OE groups after 30 min of flow. 





Figure 4.5: Flow-induced changes in cAMP levels and COX-2 expression in osteocytes 
overexpressing intact and mutated AC6 
MLO-Y4s were transfected with AC6 OE, AC6 Mut OE, or Control OE plasmids and exposed to 2 or 30 min OFF. 
After 2 min of OFF, the AC6 Mut OE group exhibits an increase in cAMP production and decreased osteogenic 
response compared to the AC6 OE group. There is no difference in cAMP production or COX-2 expression between 
the groups with 30 min of OFF. Bar graphs represented fold changes with OFF compared to static controls. AC6 OE 
and AC6 Mut OE are normalized to Control OE. Data are presented as mean ± SEM. n = 6 for all groups, *p < 0.01. 
 
 
Osteogenesis is attenuated when the TRPV4 CaM domain is removed 
Finally, we investigated changes in flow-induced osteogenesis when intact and mutated 
TRPV4 are overexpressed. We exposed cells transfected with TRPV4 OE and TRPV4 Mut OE 
to 5 and 30 min of flow to remain consistent with time points examined in our initial studies35,36. 
Regardless of flow duration, cells overexpressing TRPV4 Mut OE had an attenuated response to 
flow compared to the TRPV4 OE group. However, TRPV4 OE had significantly higher COX-2 
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Figure 4.6: Osteocytes demonstrate attenuated flow-induced osteogenesis when the CaM 
domain of TRPV4 is removed 
MLO-Y4s were transfected with TRPV4 OE, TRPV4 Mut OE, or Control OE plasmids and exposed to 5 or 30 min 
OFF. The TRPV4 Mut OE group has attenuated osteogenesis compared to the TRPV4 OE group. Bar graphs 
represented fold changes with OFF compared to static controls. TRPV4 OE and TRPV4 Mut OE data are 
normalized to Control OE data. Data are presented as mean ± SEM. n = 6 for all groups, *p < 0.01, **p < 0.001. 
 
Discussion 
These studies demonstrate, for the first time, that Ca2+ and cAMP are coupled via AC3 
and AC6 in osteocytes. AC3 and AC6 have long been known to bind Ca2+ to enhance and inhibit 
cAMP production80, respectively, but the purpose of this relationship remains poorly 
characterized in the context of cell behavior. AC5/6 expression and activity are important for 
proper heart development and function159,160 and AC5, which is also inhibited by Ca2+, is critical 
to Ca2+-mediated cardiac regulation161. AC3 is present in many tissue types and known to bind 
free Ca2+ to stimulate cAMP production162, but the cellular function of this phenomena remains 
unknown. Our lab identified that cAMP levels decrease in MLOY4 osteocytes exposed to flow 
and their fluid shear-induced osteogenic response is lost when AC6 or IFT88 is downregulated35. 
We further demonstrated that fluid flow-induced osteocyte mechanotransduction is initiated 
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when Ca2+ enters the cilium36, and mice containing a global knockout of AC6 exhibit attenuated 
load-induced bone formation48. We therefore suspected that ACs mediate Ca2+ entry and 
subsequent cAMP production, and found that AC3 and AC635 are present in MLOY4 cilia. To 
determine whether ciliary ACs mediate Ca2+/ cAMP dynamics during osteocyte mechano-
transduction, we disrupted the Ca2+ binding pocket of AC3/6 and evaluated flow-induced cAMP 
production and osteogenesis in MLO-Y4s in vitro. Indeed, osteocytes containing disrupted forms 
of AC3/6 demonstrated conflicting cAMP production compared to their functional counterparts. 
Furthermore, osteocytes that demonstrated higher levels of cAMP (AC3 OE and AC6 Mut OE) 
exhibited attenuated flow-induced osteogenesis. These results support our hypothesis that AC3/6 
bind Ca2+ to mediate cAMP production and this behavior is important for osteocyte 
mechanotransduction. 
This work also further implicates TRPV4 as the mechanism by which Ca2+ enters the 
cilium during osteocyte mechanotransduction. A prior study conducted by our lab found that an 
siRNA-mediated knockdown of TRPV4 uniquely resulted in attenuated osteogenesis in MLO-
Y4s36. We also determined that knockdown of PC2, the predominant Ca2+ channel in kidney 
cilia, does not influence osteocyte mechanotransduction. Interestingly, we show in this study that 
MLO-Y4s with supranormal TRPV4 protein levels had an enhanced osteogenic response to fluid 
shear. However, when these cells overexpressed TRPV4 that could not open to allow Ca2+ entry 
into the cell or cilium, the enhanced osteogenic response was lost. This is perhaps not surprising 
since this phenomena has also been observed in osteoclasts, which require the same TRPV4 
CaM domain to be activated for bone resorption78. Collectively, these results suggest that bone 
maintenance relies on TRPV4-mediated activation of osteocytes and osteoclasts, which promote 
and undermine bone formation, respectively.  
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AC6 is an attractive therapeutic target for bone regeneration since it can be easily 
manipulated and is potentially unique to osteocyte cilia. In this study, we demonstrated that 
MLO-Y4s overexpressing AC6 had longer cilia and an enhanced osteogenic response to fluid 
flow. This is consistent with our previous work that demonstrates cilia lengthening via 
Fenoldopam treatment promotes osteogenesis in MLO-Y4s42. Fenoldopam, an FDA-approved 
treatment for hypertension, has been proposed to enhance mechanotransduction by lengthening 
cilia via an AC/cAMP-mediated mechanism163,164. Our prior work implicates AC6 is perhaps the 
key AC in enhancing mechanotransduction via lengthening42, and this study lends further 
support. Our group also determined that AC6 is present in the osteocyte primary cilium, but not 
in kidney cilia35. More cell types must be examined, especially cardiac cells, to truly determine 
whether AC6 is unique to the osteocyte cilium. It is important to note that AC6 is expressed in 
the cell body of many cell types, including osteocytes, so therapeutic strategies would be most 
effective if targeted to the primary cilium. Although we also identified that TRPV4 is perhaps the 
predominant Ca2+ channel in osteocytes, TRPV4 is also important for osteoclast activation77,78. 
Thus, therapeutic strategies that manipulate TRPV4 to enhance osteogenesis absolutely have to 
be targeted to the osteocyte primary cilium. Similarly, AC3 is present in many cell types so any 
manipulation would need to be targeted to avoid negative side effects. Additionally, the effects 
of AC6 overexpression only affected the onset of mechanotransduction, whereas AC3 
overexpression continued to promote osteogenesis with longer durations of fluid flow. The 
primary cilium tunes its response to physical stimuli in order to prevent overstimulation165. This 
is an important negative-feedback mechanism inherent to cilium function, so therapeutic 
strategies should not interfere with this adaptation.  
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Our lab recently developed novel cilium-targeted biosensors that we will next use to 
specifically characterize Ca2+/ cAMP dynamics in the cilium. One limitation with our studies is 
that we utilize overexpression plasmids and measure cytosolic readouts. CMV-driven 
mammalian expression plasmids typically result in supranormal protein levels in the cell body, 
and are difficult to direct to a specific organelle like the primary cilium. Our ICC results suggest 
protein is also overexpressed in the primary cilium, as well as the cell body, so we have currently 
measured the impact of higher protein levels throughout the entire osteocyte. Fortunately, we 
have developed cilium-targeted genetically encoded FRET sensors that measure changes in Ca2+ 
and cAMP levels in the cilium alone36. Furthermore, we can simultaneously and distinctly 
measure changes in ciliary and cytosolic Ca2+ or cAMP. In order to specifically measure the 
effects of overexpressing TRPV4/ AC3/ AC6 in the cilium, as well as the consequences of 
disrupting their ability to bind Ca2+, we intend to measure changes in Ca2+ influx and cAMP 
production using our targeted biosensors. Indeed, our preliminary work indicates we can 
successfully transfect both our OE plasmids and our biosensor into the same cell. We are 
currently troubleshooting flow studies and live imaging to collect the final data. Another option 
is to utilize CRISPR to specifically overexpress, eliminate, or mutate ciliary AC3, AC6, and 
TRPV4. Unfortunately, this technology was not widely available at the time we generated our 
plasmids but would have been a superior approach. Despite this limitation, general 
overexpression of these ciliary proteins did enhance overall osteogenesis and we were still able 
to determine that these Ca2+ binding mechanisms are important to osteocyte 
mechanotransduction.  
Combined, our results suggest that AC6 and TRPV4 are important for the immediate 
onset of flow-induced osteocyte mechanotransduction. Specifically, we speculate that, when 
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exposed to flow, the osteocyte cilium bends and extracellular Ca2+ binds to the CaM domain of 
TRPV4 (Figure 4.7). TRPV4 then opens and Ca2+ enters the cilium, most likely in the direction 
from the ciliary base to the axoneme tip36. Ciliary Ca2+ binds to AC6, which is then unable to 
catalyze the conversion of ATP to cAMP. Consequently, cytosolic cAMP levels decrease since 
existing cAMP is recruited for flow-induced intracellular signaling and AC6 is inhibited from 




Figure 4.7: Proposed Ca2+/ cAMP dynamics in the osteocyte primary cilium microdomain  
(a) Summary of ciliary proteins and the effects of Ca2+ binding. (b) Cartoon summarizing our hypothesis of Ca2+/ 
cAMP dynamics in the osteocyte primary cilium, based on our work to date. We propose that, in the initial onset of 
fluid shear (1), extracellular Ca2+enters the bent osteocyte cilium by binding TRPV4 to facilitate opening of this 
channel, resulting in a ciliary influx of Ca2+ (2). The Ca2+ that has entered the cilium then binds to AC6 (3), 




Chapter 5: Conclusion 
Summary 
The overall goal of our work is to study the primary cilium and mechanosensitive cells to 
identify mechanisms that can be therapeutically manipulated to encourage pro-osteogenic bone 
maintenance. Collectively, the work in this thesis has revealed an exciting source of osteogenic 
precursors whose cilia can be targeted to encourage bone generation, potentially in vivo. 
Additionally, these studies identify molecular targets than can be manipulated to tune osteocyte-
mediated osteogenesis. 
In Chapter 2, we established that the Prx1-expressing population is further restricted to 
the periosteum in adult mice. We found that mice lacking this cell population were essentially 
unable to produce bone normally in response to mechanical stimulation. Additionally, we 
demonstrated that these cells are mechanosensitive and respond to physical stimuli in a pro-
osteogenic manner that requires the primary cilium. We propose that this cell source be the 
preferred source for bone generation strategies, particularly in favor of bone marrow stem cells, 
since periosteal OCPs are more easily extracted and pre-programmed towards an osteogenic fate. 
In Chapter 3, we further characterized the Prx1-expressing population and found these 
cells are predominantly restricted to the cambium layers of the periosteum/ perichondrium after 
birth. During juvenile development, these cambium layer osteochondroprogenitors (CLOPs) 
differentiate into chondrocytes that populate the epiphyseal growth plate to form trabecular bone, 
as well as osteoblasts that lay down mineralized matrix and eventually become osteocytes 
embedded in cortical bone. However, mice lacking CLOP primary cilia have significantly shorter 
and thinner limbs due to disruptions in intramembranous and endochondral ossification.  
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Finally, we identified key components that mediate Ca2+/cAMP dynamics in the 
osteocyte primary cilium microdomain. We demonstrated that AC3, AC6, and TRPV4 must bind 
Ca2+ in order to operate normally. Specifically, TRPV4 is unable to facilitate Ca2+ influx if its 
CaM binding domain is removed. Similarly, AC3 and AC6 cannot be activated or inhibited from, 
respectively, producing cAMP if their Ca2+ binding pocket is disrupted. These results provide 
further evidence that TRPV4 is perhaps the predominant calcium channel in osteocyte 
mechanotransduction. Additionally, we have established that ACs function to mediate Ca2+ and 
cAMP dynamics during osteocyte mechanotransduction. Interestingly, supranormal levels of 
AC6 protein were found to lengthen primary cilia, which is known to enhance osteocyte 
mechanosensitivity and subsequent osteogenesis. These ciliary molecules, particularly AC6, are 
therefore exciting therapeutic targets to promote bone generation via enhancing osteogenesis.       
 
Future Work 
We propose two main experiments that will effectively build upon the work conducted in 
this thesis. First, we intend to conduct fracture repair studies with our transgenic Prx1 models. 
The creators of the Prx1CreER-GFP model performed an initial fracture study using a lacZ 
reporter to track Prx1-expressing OCPs as they populated the fracture callus53. This experiment 
importantly established that Prx1-expressing cells contribute to fracture repair, but there is no 
insight into a) the mechanism by which these cells participate or b) the extent to which this cell 
population is required for repair. We propose that the primary cilium will be critical for Prx1-
expressing OCPs to populate the fracture callus; therefore, we intend to repeat the initial fracture 
study with our Prx1CreER-GFP; Ift88fl/fl cilium knockout model to ascertain the necessity of the 
primary cilium.  Another study suggests that periosteal progenitors are the predominant 
contributor of osteogenic cells in the fracture callus95. We will explore this possibility using our 
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Prx1CreER-GFP; Rosa26DTA ablation model to quantify the contribution of Prx1-expressing 
periosteal OCPs in fracture repair. We anticipate that both disruptions will negatively impact 
fracture repair, but the ablation model will be the most severe. At the completion of these 
studies, we will have a comprehensive picture of the function of Prx1-expressing OCPs and their 
primary cilia in skeletal development, adult bone maintenance, and, finally, fracture repair.  
Second, we wish to build upon the Ca2+/ cAMP studies conducted in Chapter 4. We have 
generated cilium-targeted biosensors that can quantify Ca2+ and cAMP levels distinctly in the 
cilium. We also possess the tools to simultaneously measure cytosolic changes in these two 
second messengers. Our plan is to dually transfect MLOY4s with our TRPV4 OE or TRPV4 Mut 
OE plasmids and our Ca2+ biosensor. We will use the biosensor to visualize Ca2+ influx into the 
osteocyte primary cilium when TRPV4 is overexpressed or lacking the CaM domain. We expect 
that the flow-induced ciliary Ca2+ influx will be lost without the TRPV4 CaM domain. 
Furthermore, we wish to evaluate ciliary cAMP production. We will dually transfect our AC/ 
Mut OE plasmids with our biosensors and measure cytosolic and ciliary changes in cAMP to 
gain insight on ciliary/cytosolic relationships during the onset of mechanotransduction. 
Eventually, we intend to design and test methods that target the osteocyte primary cilium in order 
to develop pro-osteogenic therapeutics without side effects.  
 
Significance  
We believe the work performed in this thesis achieves two significant impacts. First, we 
have characterized a promising source of osteogenic precursors to generate new bone in areas 
where it is needed. Furthermore, we have elucidated the importance of the primary cilium in this 
cell source’s ability to respond to mechanical stimuli and differentiate to produce skeletal tissue. 
This work provides critical insights that can alleviate patients suffering from bone fractures and 
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critical size defects. Over 1 million surgeries performed each year in the US involve fracture 
repair, partial excision of bone, and grafting7,8. Bone marrow was first identified as a source, but 
extraction is painful and progenitors require further encouragement towards an osteogenic 
lineage. The periosteum is a rich source of OCPs and is easily accessible for extraction84,85. 
Furthermore, it may be better suited for bone regeneration since periosteal progenitors largely 
contribute to deposition of bone and cartilage during bone repair in vivo53,54,95,166. One strategy to 
encourage osteogenic differentiation is to target OCP primary cilia37,48,82,98. Our lab is among the 
first to identify the primary cilium as a mechanosensitive signaling nexus that contributes to 
progenitor activation and osteogenic commitment39,40,94. This thesis provides compelling 
preliminary data indicating Prx1-expressing OCPs and their cilia contribute significantly to 
juvenile development and adult bone formation. In the long term, the knowledge generated in 
this research may even make it possible to populate remote sites of bone formation by 
manipulating cilia, obviating the need for extraction. This contribution is significant because it 
motivates 1) utilizing the periosteum in the short-term as a primary source of progenitors for 
regenerative strategies and 2) pursuing ciliary therapies in the long-term to non-invasively 
generate bone where it is needed. Independently, both of these contributions will ultimately 
reduce graft donor site morbidity, patient discomfort, and financial burden.  
Second, our in vitro studies that identify a mechanism for osteocyte mechanotransduction 
provides unique opportunities to combat osteoporosis in a pro-osteogenic manner. Current 
pharmaceutical osteoporosis therapies protect or restore bone mass to varying degrees, yet still 
have adverse side effects. Antiresorptive drugs are associated with increased rate of atypical 
fractures [2], mandibular necrosis [3], esophageal cancer, and atrial fibrillation [4]. Several 
anabolic therapies can only be used for a limited time or have a potential risk of osteosarcoma 
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[5]. Since skeletal loading is a natural anabolic stimulus, targeting the osteocyte mechanosensing 
system has great potential to uncover new therapeutic strategies. In this thesis, we identified AC6 
as a potential target for manipulating osteogenesis that is potentially unique to the osteocyte 
primary cilium. Furthermore, we identified that AC3 and TRPV4, if properly targeted to the 
osteocyte primary cilium, can also be potentially manipulated to enhance osteogenesis. These 
contributions are significant because they are an important advancement in the research 
continuum leading to novel therapeutics that shift the bone remodeling balance to promote bone 
formation. It is our hope that pro-osteogenic strategies will minimize adverse side effects and 
produce longer lasting results that alleviate the taxing dosing regimens associated with current 
treatments. 
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